0.40 230000000 200000000 0.60 65400000 45000000 720000000 47400000 142100000 1806000000 200000000 3300000000 765000000 2790000000 3555000000 340000000 3555000000 412000000 0.925 14.25 303000000 328000000 155000000 102000000 300000000 14.25 86000000 230000000 174000000 88000000 257000000 7538520276 22500000000 13500000000 10500000000 24000000000 163000000000 19300000 2800000 36062000000 23303000000 140000000 4200000000 326000000 1300000000 22117000000 46445000000 68562000000 570000000 7971000000 68236000000 68236000000 9838000000 1339600000 0.985 50.40 13822000000 23738000000 16366000000 33.00 17.40 260000000 23700000000 1800000000 300000000 14400000000 10500000000 44208000000 405000000 320000000 2394000000 11187000000 3175000000 1908000000 1200000000 2800000000 500000000 11100000000 14000000000 2100000000 17.66 200000000 60000000 455000000 400000000 200000000 500000000 0.70 19000000 2122000000 57740000000 5372000000 11 38700000 49142000000 -3132000000 10000000 57556000000 184000000 -4569000000 -4569000000 8863000000 443000000 1804 73000000 -24000000 -425000000 -2117000000 -57391000000 -86000000 -1389000000 28000000 70283000000 42357000000 1978000000 90446000000 7657000000 198000000 147000000 12578000000 0.040 0.063 9977000000 843000000 454000000 9049000000 0.036 0.051 6516000000 127000000 346000000 3733000000 0.060 370000000 1368000000 0.040 0.062 154000000 9883000000 20038000000 3272000000 9010000000 13 40426000000 -3367000000 94000000 90014000000 432000000 552000000 552000000 8869000000 443000000 1511 61000000 -19000000 -333000000 -799000000 -21632000000 269000000 3550000000 6000000 70497000000 9440000000 894000000 999000000 -3440000000 22712000000 28636000000 13200000000 554000000 -14604000000 38410000000 467000000 4126000000 42716000000 13380000000 195014000000 444000000 8275000000 452000000 9524000000 0.028 151000000 11744000000 6245000000 27000000 61013000000 43928000000 951000000 27402000000 5601000000 791000000 15915000000 1735000000 1178000000 0.05 13729000000 70760000000 208000000 3665000000 18628000000 31377000000 15021000000 12732000000 1601000000 2146000000 601000000 5603000000 195014000000 1439000000 1279 52000000 132000000 17104000000 87813000000 8876000000 71228000000 883000000 43826000000 26277000000 18645000000 29625000000 3502000000 9747000000 12000000000 106749000000 864000000 952000000 -7000000 3994000000 3727000000 6194000000 299000000 88265000000 57555000000 2080000000 6759000000 3035000000 42300000000 1165000000 420000000 29625000000 59000000 14256000000 84957000000 44013000000 3078000000 1134000000 38622000000 906000000 515000000 710000000 44897000000 339000000 545000000 3000000000 5800000000 1000000000 1321000000 1359000000 1411000000 4575000000 452000000 112000000 56000000 70000000 3000000000 1200000000 108000000 4643000000 4479000000 2500000000 230000000 41177000 17.57 178000000 28.29 458604000 13035000000 2699000000 -2439000000 10596000000 13035000000 63000000 581000000 12000000000 0.422 2439000000 11953000000 0.040 -2636000000 0.336 0.059 10596000000 10596000000 1 -2439000000 0.113 0.129 6464000000 1196000000 1708000000 817000000 2083000000 660000000 2765000000 2765000000 1367000000 1000000 2000000 899000000 465000000 899000000 465000000 1196000000 1708000000 2766000000 817000000 2085000000 660000000 899000000 465000000 8283000000 2388000000 -2433000000 2228000000 9132000000 118000000 -18000000 8100000000 0.498 2510000000 4069000000 0.035 -2406000000 0.316 0.048 6699000000 5731000000 1 -2433000000 41000000 0.077 0.109 4935000000 518000000 1881000000 292000000 804000000 376000000 932000000 4000000 59000000 69000000 1166000000 1166000000 598000000 215000000 366000000 17000000 215000000 366000000 518000000 1881000000 1458000000 804000000 376000000 932000000 21000000 274000000 435000000 451000000 -3168000000 3582000000 581000000 0.113 3035000000 130000000 0.089 2027 0.056 414000000 1 -3168000000 133000000 0.029 0.769 385000000 12000000 18000000 9000000 21000000 7000000 12000000 306000000 29000000 29000000 12000000 18000000 29000000 9000000 21000000 7000000 12000000 306000000 1401000000 525000000 -1401000000 1401000000 21000000 1200000000 1245000000 1177000000 0.040 -504000000 0.058 -1401000000 156000000 2449000000 18274000000 496000000 6050000000 16659000000 0.18 8537000000 2095000000 7159000000 854000000 72000000 3438000000 10219000000 35544000000 884000000 257000000 494000000 4000000 603000000 173000000 623000000 128000000 32699000000 230000000 1217000000 18 1200000000 186000000 326000000 494000000 257000000 603000000 3000000 1000000 93000000 17000000 21000000 107000000 79000000 544000000 105000000 2000000000 880000000 26223000000 68432000000 42209000000 248000000 637000000 389000000 324000000 533000000 209000000 607000000 1626000000 1019000000 625000000 42716000000 -3947000000 389000000 87813000000 452000000 -3440000000 -3440000000 8876000000 444000000 1279 52000000 -7000000 -864000000 -22712000000 157000000 169000000 -208000000 70760000000 279000000 169000000 5500000000 421000000 369000000 3000000 186000000 151000000 124000000 19000000 1439000000 1009000000 27000000 130000000 47000000 45000000 3543000000 3247000000 3000000000 2665000000 2662000000 2564000000 2466000000 2306000000 2089000000 1921000000 1608000000 1322000000 1302000000 1074000000 3464000000 2342000000 835000000 122000000 718000000 112000000 9441000000 144000000 1201000000 1139000000 -4129000000 31801000000 28069000000 12804000000 125000000 9400000000 -14635000000 34931000000 51000000 4979000000 2526000000 46210000000 3987000000 3074000000 13608000000 188002000000 105000000 445000000 7769000000 431000000 11699000000 0.002 11541000000 6886000000 27000000 57728000000 4500000000 45067000000 1013000000 33277000000 6199000000 747000000 16612000000 3539000000 1155000000 500000000 0.05 11296000000 71423000000 227000000 2765000000 19597000000 30522000000 15411000000 166000000 13584000000 319000000 1796000000 1326000000 1197000000 4018000000 188002000000 101000000 1112 45000000 2574.87 19406000000 324000000 16014000000 83000000 82190000000 8902000000 75814000000 885000000 42537000000 23219000000 40300 723000000 16938000000 30046000000 6000000 9457000000 12000000000 105381000000 187000000 1327000000 951000000 -3000000 3836000000 4119000000 6355000000 381000000 82621000000 53833000000 3964000000 2169000000 7309000000 3344000000 40100000000 30334000000 1713000000 226000000 30046000000 52000000 15237000000 6414000000 23370000000 87110000000 2300000000 38949000000 2607000000 1020000000 35026000000 900000000 357000000 1042000000 40714000000 459000000 1306000000 3300000000 6100000000 1200000000 1611000000 554000000 1812000000 4414000000 476000000 211000000 524000000 95000000 4000000000 1200000000 291000000 4291000000 550000000 4285000000 2100000000 0.15 0.85 2300000000 264000000 41940000 17.27 17.08 421754000 177000000 16.31 25.31 751000000 25.46 17.41 17000000 4.9 38.73 715000000 18.92 30.09 273563000 429553000 475000000 14835000000 825000000 4638000000 -2830000000 12005000000 14835000000 19000000 123000000 2000000 13800000000 806000000 0.360 2830000000 13799000000 0.035 -4515000000 0.304 4891000000 839000000 819000000 0.051 12005000000 874000000 12005000000 1 -2830000000 0.176 0.160 1.03 7911000000 2111000000 1794000000 12000000 870000000 1966000000 805000000 353000000 2509000000 2509000000 1585000000 1000000 5000000 3000000 920000000 656000000 920000000 656000000 2111000000 1794000000 2522000000 870000000 1971000000 808000000 920000000 656000000 353000000 4951000000 416000000 2020000000 -1936000000 2529000000 9054000000 329000000 431000000 -21000000 8300000000 403000000 0.500 2224000000 4446000000 0.033 -2041000000 0.329 2496000000 455000000 436000000 0.047 7118000000 394000000 2686000000 1 -1936000000 41000000 0.044 0.127 4920000000 311000000 2047000000 81000000 786000000 542000000 1015000000 4000000 67000000 67000000 1432000000 1432000000 766000000 349000000 366000000 51000000 349000000 366000000 311000000 2047000000 1513000000 786000000 542000000 1015000000 55000000 416000000 433000000 317000000 759000000 -3478000000 3900000000 394000000 468000000 308000000 0.097 3344000000 -291000000 0.081 1780000000 331000000 326000000 2027 0.048 422000000 295000000 1 -3478000000 134000000 0.046 0.776 398000000 19000000 17000000 8000000 19000000 8000000 15000000 312000000 24000000 24000000 19000000 17000000 24000000 8000000 19000000 8000000 15000000 312000000 1431000000 174000000 566000000 -1431000000 1431000000 130000000 26000000 1200000000 173000000 1301000000 1225000000 0.035 -540000000 706000000 141000000 165000000 0.050 130000000 -1431000000 130000000 0.05 0.01 2497000000 0.02 0.02 0.14 0.51 0.57 18746000000 0.08 0.26 0.17 0.29 498000000 0.23 0.01 6229000000 0.14 0.15 0.57 17097000000 0.14 0.64 1155000000 5000000 1150000000 0.13 5431000000 5688000000 257000000 3921000000 6526000000 284000000 2321000000 2234000000 9000000 2225000000 1872000000 2305000000 433000000 1101000000 1354000000 253000000 9895000000 11072000000 1177000000 7893000000 2118000000 6023000000 904000000 72000000 1197000000 10027000000 10000 67700 32419000000 1765000000 355000000 349000000 14000000 1033000000 154000000 1396000000 17000000 29179000000 317000000 1370000000 18 2434000000 92000000 928000000 1600000000 555000000 502000000 46000000 48100000000 10600000000 2700000000 491000000 141000000 169000000 349000000 355000000 8000000 8000000 1000000000 14000000 123000000 17000000 104000000 1300000000 85000000 25000000 919000000 32013000000 73088000000 41075000000 215000000 425000000 210000000 362000000 623000000 261000000 687000000 1678000000 991000000 3555000000 625000000 85000000 46210000000 -5120000000 362000000 82190000000 431000000 -4129000000 -4129000000 8902000000 445000000 1112 45000000 -3000000 -1327000000 -31801000000 46000000 944000000 -361000000 4000000 3000000 45000000 71423000000 63000000000 11000000 225000000 6000000000 357000000 677000000 8600000000 7500000000 7000000000 0.0445 3248000000 0.062 3069000000 0.0535 2583000000 0.0475 2581000000 0.0575 2948000000 0.072 2392000000 0.03625 2306000000 0.065 2088000000 0.0595 1893000000 0.055 1564000000 0.055 1325000000 0.0455 1266000000 0.0475 1061000000 0.055 3440000000 0.0651 18 2302000000 0.0528 5 865000000 0.0248 4 2000000 829000000 120000000 8000000 425000000 1200000000 28000000000 11662000000 14188000000 8167000000 10602000000 57400 42800 2564000000 2564000000 931000000 1022000000 -326000000 2011-11-30 0.80 430000000 0.75 40000 2400000000 405000000 P10Y 215000000 5000000000 The court granted Pfizer's motion for a new trial and vacated the jury verdict 10000000000 186000000 23303000000 -5775000000 747000000 -91000000 5000000 8000000 270000000 -6000000 168000000 234000000 -31272000000 191000000 874000000 -62000000 -0.051 -252000000 7824000000 2300000000 6504000000 8521000000 4916000000 16587000000 712000000 569000000 0.02 79000000 188000000 8459000000 5548000000 43000000 349000000 8529000000 1.23 670000000 5127000000 -218000000 1501000000 6888000000 -0.094 -100000000 1232000000 -9590000000 250000000 941000000 139000000 -0.001 967000000 8635000000 8635000000 9454000000 349000000 10674000000 15000000 400000000 305000000 3000000000 1.22 38000000 4757000000 27000000000 8633000000 1.21 17000000 1205000000 23633000000 1.23 2877000000 49269000000 -199000000 13770000000 35331000000 -0.013 31159000000 97000000 5000000 99000000 191000000 2900000000 0.002 14752000000 2145000000 -144000000 7007000000 60000000 34000000 159000000 935000000 -1631000000 42364000000 0.201 68000000 0.02 7045000000 43123000000 14481000000 114000000 -285000000 2000000 243000000 24023000000 851000000 8643000000 38000000 0.35 -54000000 241000000 417000000 768000000 4821000000 2564000000 250000000 8519000000 485000000 546000000 34969000000 4330000000 0.024 8000000 50000000 -10000000 1158000000 565000000 61000000 482000000 676000000 2925000000 3601000000 175000000 -10000000 361000000 -37000000 150000000 -0.016 1785000000 284000000 356000000 1.3 183000000 131000000 3000000 0.0235 15000000 5.00 0.0455 0.3692 2000000 0.0269 7000000 1000000 3.30 1.2 165000000 6.00 0.0490 0.4136 0.0195 -17000000 3 0.4040 0.3630 252000000 636000000 527000000 -783000000 61000000 0.085 110000000 2000000 526000000 0.064 -212000000 0.043 -147000000 188000000 193000000 375000000 1004000000 8000000 0.067 3000000 -3000000 342000000 0.056 -30000000 0.032 1197000000 39000000 194000000 26000000 -122000000 24000000 0.085 -3000000 -3000000 145000000 0.064 -18000000 72000000 24000000 241000000 -23000000 137000000 -2000000 -2000000 53000000 0.064 -31000000 0.043 218000000 0.10 3156000000 27528000000 901000000 48706000000 1296000000 781000000 -4657000000 526000000 13000000 -4025000000 241000000 297000000 250000000 812000000 142000000 3258000000 56000000 -1511000000 392000000 6955000000 360000000 13947000000 2706000000 -2751000000 181000000 563000000 -4000000 560000000 -123000000 109000000 550000000 900000000 290000000 1407000000 15100000000 130000000 22576000000 37000000 -3787000000 2799000000 1060000000 4661000000 269000000 8925000000 339000000 292000000 1300000000 21540000000 7046000000 12586000000 10000000000 8097000000 72000000 -556000000 1300000000 0.383 0.284 1.41 11436000000 904000000 67859000000 2400000000 200000000 834000000 88000000 316000000 320000000 129000000 Two-and-a-half months One-and-a-half months 5000000 4916000000 -12430000000 8635000000 19000000 -701000000 291000000 -196000000 390000000 56000000 154000000 -6000000 -3000000 -5000000 5000000 66000000 4916000000 5121000000 -207000000 139000000 23303000000 13756000000 8635000000 50000000 -10000000 102000000 6000000 -11000000 330000000 14000000 5000000 8000000 5121000000 4978000000 213000000 867000000 -437000000 -547000000 285000000 -197000000 385000000 6000000 -12000000 -293 28000000 9000000 -2000000 111000000 7000000 1319000000 -23000000 35733000000 -1000000 3000000 78000000 576000000 -143000000 4978000000 46000000 5000000 2000000 14000000 291000000 -299000000 66000000 -212000000 130000000 -61000000 -1000000 -10005000000 68000000 10151000000 -3694000000 -93000000 121000000 1516000000 14368000000 508000000 2024000000 500000000 15000000 -2000000 740000000 17000000 51000000 148000000 97000000 114000000 8000000 2764000000 494000000 191000000 372000000 45448000000 4913000000 2925000000 435000000 483000000 98000000 81000000 548000000 457000000 2383000000 700000000 1154000000 520000000 378000000 359000000 887000000 1002000000 11434000000 2840000000 457000000 1973000000 213000000 287000000 82000000 57000000 47000000 450000000 964000000 54000000 798000000 1892000000 1737000000 430000000 516000000 184000000 1141000000 327000000 326000000 318000000 281000000 270000000 245000000 204000000 130000000 241000000 21000000 59000000 147000000 55000000 36000000 133000000 46000000 9000000 53000000 159000000 153000000 -5950000000 402000000 1000000000 66000000 61000000 3000000 31000000 191000000 -5000000 1737000000 -492000000 259000000 -1297000000 130000000 608000000 9392000000 11775000000 4381000000 8180000000 5964000000 11454000000 1004000000 0.01 513000000 262000000 15838000000 6088000000 12000000 405000000 8211000000 1.02 155000000 -3987000000 -62000000 824000000 3920000000 0.022 -118000000 1797000000 1937000000 276000000 1396000000 175000000 -0.012 6000000 8257000000 8257000000 -12666000000 405000000 9282000000 -11000000 413000000 3486000000 5500000000 1.02 2384000000 8487000000 5300000000 8255000000 1.01 2254000000 -11000000 1513000000 1.03 5403000000 67057000000 19000000 4301000000 10931000000 -0.023 -0.264 6400000000 88000000 17000000 129000000 4000000000 0.005 19480000000 1071000000 -243000000 8036000000 -31000000 36000000 870000000 2155000000 -2917000000 4543000000 0.115 683000000 1000000000 125000000 0.01 8074000000 273000000 -11174000000 -702000000 77000000 -4336000000 2000000 579000000 906000000 8288000000 38000000 0.35 -88000000 788000000 2175000000 22000000 3989000000 1114000000 8178000000 1395000000 -688000000 9249000000 3201000000 0.005 16000000 273000000 -8000000 1156000000 151000000 356000000 208000000 710000000 4084000000 4794000000 124000000 131000000 316000000 -37000000 147000000 545000000 0.028 0.004 49000000 -280000000 -104000000 387000000 1300000000 -97000000 -91000000 -241000000 -1000000 -454000000 20000000 -1054000000 -704000000 2000000 -6000000 1000000 1.4 211000000 311000000 2000000 0.0234 28000000 5.00 0.0399 0.2676 5000000 0.0287 16000000 1000000 3.25 1.3 150000000 6.25 0.0400 0.2685 0.0124 14000000 3 0.2675 0.2364 347000000 479000000 782000000 260000000 1000000 -980000000 73000000 0.085 -52000000 905000000 2000000 73000000 905000000 233000000 740000000 0.063 -151000000 0.040 1123000000 -500000000 901000000 -46000000 739000000 -31000000 42000000 45000000 -10000000 21000000 230000000 289000000 434000000 152000000 10000000 -361000000 6000000 0.064 -3000000 53000000 -504000000 -4000000 6000000 18000000 53000000 33000000 427000000 0.051 -67000000 0.036 454000000 -315000000 -376000000 455000000 -3000000 441000000 58000000 37000000 -4000000 -3000000 52000000 -10000000 -34000000 12000000 79000000 232000000 31000000 -183000000 -281000000 19000000 0.085 -23000000 4000000 -38000000 0.080 19000000 22000000 -1000000 211000000 0.045 0.060 -15000000 46000000 -273000000 249000000 -495000000 49000000 28000000 313000000 117000000 -1000000 -180000000 180000000 1000000 235000000 -2000000 180000000 235000000 29000000 77000000 0.062 -29000000 0.040 -161000000 396000000 -6000000 430000000 0.10 3977000000 38013000000 1248000000 64870000000 1567000000 455000000 -7990000000 619000000 396000000 34000000 -3989000000 788000000 428000000 46000000 2290000000 1569000000 197000000 19000000 6347000000 14000000 18000000 -3964000000 292000000 452000000 43000000 8573000000 10100000000 418000000 32000000 18760000000 214000000 182000000 -22012000000 2163000000 189000000 3743000000 -3263000000 242000000 2187000000 4000000 496000000 385000000 27000000 -1268000000 113000000 1473000000 71000000 2838000000 15773000000 201000000 11000000 23328000000 71000000 145000000 26000000 -8257000000 5477000000 54000000 1624000000 197000000 7815000000 10571000000 432000000 29000000 16435000000 195000000 708000000 292000000 1100000000 13000000 550000000 950000000 700000000 3 0.14 0.1 0.09 28855000000 11849000000 16345000000 12000000000 10008000000 -1489000000 -434000000 1300000000 800000000 0.99 8013000000 160000000 68432000000 190000000 35000000 224000000 116000000 2200000000 3000000 5964000000 8257000000 -230000000 -1426000000 262000000 88000000 266000000 169000000 550000000 -42000000 5000000 -49000000 3000000 5964000000 -3992000000 -61000000 175000000 4265000000 1000000000 8257000000 273000000 -8000000 5000000 -1000000 36000000 17000000 31000000 -3992000000 -3544000000 -375000000 -1036000000 554000000 -876000000 220000000 98000000 217000000 -1000000 7000000 -9000000 -232 1000000 -20000000 14000000 2000000 292000000 16000000 -61000000 82000000 -4000000 1000000000 2000000 -22000000 7000000 -141000000 -3544000000 -165000000 -7000000 5000000 -127000000 -1043000000 702000000 -122000000 161000000 -19000000 -1000000 2010000000 -315000000 -2763000000 -2513000000 -6000000 -1074000000 600000000 2212000000 11795000000 -67000000 2145000000 506000000 320000000 140000000 270000000 500000000 -11000000 752000000 -11000000 52000000 140000000 88000000 77000000 16000000 3575000000 2772000000 1867000000 320000000 58523000000 6194000000 4084000000 454000000 483000000 643000000 400000000 527000000 413000000 2374000000 755000000 1013000000 1718000000 3274000000 341000000 885000000 1027000000 10733000000 3063000000 455000000 1506000000 1040000000 1253000000 466000000 388000000 404000000 481000000 1066000000 324000000 825000000 1928000000 1749000000 415000000 532000000 952000000 1176000000 322000000 323000000 307000000 278000000 250000000 244000000 213000000 157000000 214000000 164000000 137000000 157000000 2416000000 34000000 527000000 227000000 FY No PFE PFIZER INC Yes false Large Accelerated Filer 2011 10-K 2011-12-31 0000078003 Yes --12-31 79000000 -10874000000 458000000 9000000000 <div> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><b>Q. Legal and Environmental Contingencies</b></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">We and certain of our subsidiaries are subject to numerous contingencies arising in the ordinary course of business, such as patent litigation, product liability and other product-related litigation, commercial litigation, environmental claims and proceedings, government investigations and guarantees and indemnifications. We record accruals for these contingencies to the extent that we conclude that a loss is both probable and reasonably estimable. If some amount within a range of loss appears to be a better estimate than any other amount within the range, we accrue that amount. Alternatively, when no amount within a range of loss appears to be a better estimate than any other amount, we accrue the lowest amount in the range. We record anticipated recoveries under existing insurance contracts when recovery is assured.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Amounts recorded for contingencies can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions. For information about the risks associated with estimates and assumptions, see <i>Note 1C. Significant Accounting Policies: Estimates and Assumptions.</i></font></p> </div> 168000000 459000000 3000000 <div> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><font style="FONT-FAMILY: ARIAL" size="1">Basic and diluted EPS were computed using the following common share data:</font></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="80%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="12">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;YEAR&#xA0;ENDED&#xA0;DECEMBER&#xA0;31,&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; &#xA0;&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">(IN MILLIONS)</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom" colspan="2" align="right"> <font style="FONT-FAMILY: ARIAL" size="1"><b>2011</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2010</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2009&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="12">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1"><b>EPS Numerator&#x2014;Basic:</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Income from continuing operations</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$&#xA0;&#xA0;8,739</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$8,211</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$8,529&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Less: Net income attributable to noncontrolling interests</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>42</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">31</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">8&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="12">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Income from continuing operations attributable to Pfizer Inc.</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>8,697</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">8,180</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">8,521&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Less: Preferred stock dividends&#x2014;net of tax</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="12">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Income from continuing operations attributable to Pfizer Inc. common shareholders</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>8,695</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">8,178</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">8,519&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Discontinued operations&#x2014;net of tax</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,312</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">77</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">114&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="12">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Net income attributable to Pfizer Inc. common shareholders</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$10,007</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$8,255</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$8,633&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1"><b>EPS Numerator&#x2014;Diluted:</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$&#xA0;&#xA0;8,697</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$8,180</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$8,521&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Discontinued operations&#x2014;net of tax</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,312</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">77</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">114&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="12">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Net income attributable to Pfizer Inc. common shareholders and assumed conversions</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$10,009</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$8,257</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$8,635&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1"><b>EPS Denominator:</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Weighted-average number of common shares outstanding&#x2014;Basic</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>7,817</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">8,036</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">7,007&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Common-share equivalents: stock options, stock issuable under employee compensation plans and convertible preferred stock</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>53</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">38</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">38&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="12">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Weighted-average number of common shares outstanding&#x2014;Diluted</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>7,870</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">8,074</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">7,045&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>272</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">413</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">400&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> </tr> <!-- End Table Body --></table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">These common stock equivalents were outstanding during 2011, 2010 and 2009 but were not included in the computation of diluted EPS for those years because their inclusion would have had an anti-dilutive effect.</font></p> </td> </tr> </table> </div> <div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="3%"></td> <td valign="bottom" width="1%"></td> <td width="96%"></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr> <td valign="top"><font style="FONT-FAMILY: ARIAL" size="4"><b>12.</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="top"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 3px"> &#xA0;</p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px"><font style="FONT-FAMILY: ARIAL" size="2"><b>Equity</b></font></p> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><b>A. Common Stock</b></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">During 2009, in connection with our acquisition of Wyeth on October&#xA0;15, 2009, we issued approximately 1.3 billion shares of common stock, which were previously held as Pfizer treasury stock, to former Wyeth shareholders to partially fund the acquisition. The excess of the average cost of Pfizer treasury stock issued over the fair value of the stock portion of the consideration transferred to acquire Wyeth was recorded as a reduction to <i>Retained Earnings</i>. We purchase our common stock via privately negotiated transactions or in open market purchases as circumstances and prices warrant. Purchased shares under each of the share-purchase plans, which are authorized by our Board of Directors, are available for general corporate purposes.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">From June 2005 through year-end 2011, we purchased approximately 1.2 billion shares of our stock for approximately $28 billion. On February&#xA0;1, 2011, we announced that the Board of Directors authorized a new $5 billion share-purchase plan. On December&#xA0;12, 2011, we announced that the Board of Directors authorized an additional $10 billion share-purchase plan. In 2011, we purchased approximately 459&#xA0;million shares of our common stock for approximately $9.0 billion. In 2010, we purchased approximately 61&#xA0;million shares of our common stock for approximately $1.0 billion. We did not purchase any shares of our common stock in 2009.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">After giving effect to share purchases through year-end 2011, our remaining share-purchase authorization is approximately $10 billion at December&#xA0;31, 2011.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><b>B. Preferred Stock</b></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">The Series A convertible perpetual preferred stock is held by an Employee Stock Ownership Plan (Preferred ESOP) Trust and provides dividends at the rate of 6.25%, which are accumulated and paid quarterly. The per-share stated value is $40,300 and the preferred stock ranks senior to our common stock as to dividends and liquidation rights. Each share is convertible, at the holder&#x2019;s option, into 2,574.87 shares of our common stock with equal voting rights. The conversion option is indexed to our common stock and requires share settlement, and, therefore, is reported at the fair value at the date of issuance. We may redeem the preferred stock at any time or upon termination of the Preferred ESOP, at our option, in cash, in shares of common stock or, a combination of both at a price of $40,300 per share.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><b>C. Employee Stock Ownership Plans</b></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">We have two employee stock ownership plans (collectively, the ESOPs), the Preferred ESOP and another that holds common stock of the Company (Common ESOP).</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Allocated shares held by the Common ESOP are considered outstanding for the earnings per share (EPS) calculations and the eventual conversion of allocated preferred shares held by the Preferred ESOP is assumed in the diluted EPS calculation. As of December&#xA0;31, 2011, the Preferred ESOP held preferred shares with a stated value of approximately $45 million, convertible into approximately 3&#xA0;million shares of our common stock. As of December&#xA0;31, 2011, the Common ESOP held approximately 4&#xA0;million shares of our common stock. As of December&#xA0;31, 2011, all preferred and common shares held by the ESOPs have been allocated to the Pharmacia U.S. and certain Puerto Rico savings plan participants.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> &#xA0;</p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><b>D. Employee Benefit Trust</b></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">The Pfizer Inc. Employee Benefit Trust (EBT) was established in 1999 to fund our employee benefit plans through the use of its holdings of Pfizer Inc. stock. Our consolidated balance sheets reflect the fair value of the shares owned by the EBT as a reduction of <i>Shareholders&#x2019; equity.</i> Beginning in May 2009, the Company began using the shares held in the EBT to help fund the Company&#x2019;s matching contribution in the Pfizer Savings Plan.</font></p> </div> 4856000000 42000000 127000000 45000000 790000000 2200000000 <div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><font style="FONT-FAMILY: ARIAL" size="1">The components of our long-term debt follow:</font></font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="76%"></td> <td valign="bottom" width="1%"></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="10"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: ARIAL" size="1">AS&#xA0;OF&#xA0;DECEMBER&#xA0;31,</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">(MILLIONS OF DOLLARS)</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: ARIAL" size="1">MATURITY&#xA0;DATE</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom" colspan="2" align="right"> <font style="FONT-FAMILY: ARIAL" size="1"><b>2011</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2010&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="10"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Senior unsecured notes:</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">6.20%<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">March&#xA0;2019</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$&#xA0;&#xA0;3,248</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$&#xA0;&#xA0;3,247&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">5.35%<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">March 2015</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>3,069</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">3,000&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">7.20%<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">March 2039</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2,948</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,564&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">4.75% euro<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">June 2016</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2,583</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,665&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">5.75% euro<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">June 2021</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2,581</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,662&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">3.625% euro<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">June 2013</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2,392</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,466&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">6.50% U.K. pound<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">June 2038</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2,306</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,306&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">5.95%</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">April 2037</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2,088</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,089&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">5.50%</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">February&#xA0;2014</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,893</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,921&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">5.50%</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">March 2013</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,564</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,608&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">4.55% euro</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">May 2017</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,325</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,322&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">4.75% euro</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">December&#xA0;2014</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,266</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,302&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">5.50%</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">February 2016</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,061</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,074&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">4.45%<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">March 2012</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2013;&#x2013;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">3,543&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Notes and other debt with a weighted-average interest rate of 5.28%<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(d)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">2012&#x2013;2018</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2,302</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,342&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Notes and other debt with a weighted-average interest rate of 6.51%<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(e)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">2021&#x2013;2036</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>3,440</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">3,464&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Foreign currency notes and other foreign currency debt with a weighted-<br /> average interest rate of 2.48%<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(f)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">2014-2016</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>865</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">835&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="10"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Total long-term debt</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$34,931</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$38,410&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="10"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Current portion not included above</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$6</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$&#xA0;&#xA0;3,502&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="10"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <!-- End Table Body --></table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Instrument is callable by us at any time at the greater of 100% of the principal amount or the sum of the present values of the remaining scheduled payments of principal and interest discounted at the U.S. Treasury rate plus 0.50% plus, in each case, accrued and unpaid interest.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Instrument is callable by us at any time at the greater of 100% of the principal amount or the sum of the present values of the remaining scheduled payments of principal and interest discounted at a comparable government bond rate plus 0.20% plus, in each case, accrued and unpaid interest.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">At December&#xA0;31, 2011, the note was called.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(d)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Contains debt issuances with a weighted-average maturity of approximately 5 years.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(e)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Contains debt issuances with a weighted-average maturity of approximately 18 years.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(f)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;Contains debt issuances with a weighted-average maturity of approximately 4 years.</font></p> </td> </tr> </table> </div> 288000000 <div> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><b>R. Share-Based Payments</b></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Our compensation programs can include share-based payments. All grants under share-based payment programs are accounted for at fair value and these fair values generally are amortized on a straight-line basis over the vesting terms into <i>Cost of sales, Selling, informational and administrative expenses,</i> and <i>Research and development expenses</i>, as appropriate.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Amounts recorded for share-based compensation can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions. For information about the risks associated with estimates and assumptions, see <i>Note 1C. Significant Accounting Policies: Estimates and Assumptions</i>.</font></p> </div> -7540000000 <div> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><font style="FONT-FAMILY: ARIAL" size="1">Information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk follows:</font></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="48%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="24"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="bottom"> <p style="BORDER-BOTTOM: #000000 1px solid">&#xA0;<font size="1">&#xA0;</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"><font style="FONT-FAMILY: ARIAL" size="1">AMOUNT OF</font><br /> <font style="FONT-FAMILY: ARIAL" size="1">GAINS/(LOSSES)</font><br /> <font style="FONT-FAMILY: ARIAL" size="1">RECOGNIZED&#xA0;IN&#xA0;OID<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a),&#xA0;(b),&#xA0;(c)</sup></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"><font style="FONT-FAMILY: ARIAL" size="1">AMOUNT OF</font><br /> <font style="FONT-FAMILY: ARIAL" size="1">GAINS/(LOSSES)</font><br /> <font style="FONT-FAMILY: ARIAL" size="1">RECOGNIZED&#xA0;IN&#xA0;OCI</font><br /> <font style="FONT-FAMILY: ARIAL" size="1">(EFFECTIVE&#xA0;PORTION)<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a),&#xA0;(d)</sup></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"><font style="FONT-FAMILY: ARIAL" size="1">AMOUNT OF</font><br /> <font style="FONT-FAMILY: ARIAL" size="1">GAINS/(LOSSES)</font><br /> <font style="FONT-FAMILY: ARIAL" size="1">RECLASSIFIED&#xA0;FROM</font><br /> <font style="FONT-FAMILY: ARIAL" size="1">OCI INTO OID</font><br /> <font style="FONT-FAMILY: ARIAL" size="1">(EFFECTIVE&#xA0;PORTION)<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a),&#xA0;(d)</sup></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">(MILLIONS OF DOLLARS)</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom" colspan="2" align="right"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1"><b>Dec. 31,</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1"><b>2011</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="right"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1">Dec. 31,&#xA0;&#xA0;</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1">2010&#xA0;&#xA0;</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom" colspan="2" align="right"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1"><b>Dec.&#xA0;31,</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1"><b>2011</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="right"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1">Dec.&#xA0;31,&#xA0;&#xA0;</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1">2010&#xA0;&#xA0;</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom" colspan="2" align="right"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1"><b>Dec.&#xA0;31,</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1"><b>2011</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="right"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1">Dec.&#xA0;31,&#xA0;&#xA0;</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="right"> <font style="FONT-FAMILY: ARIAL" size="1">2010&#xA0;&#xA0;</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td bgcolor="#E6E7E8" valign="bottom">&#xA0;</td> <td bgcolor="#E6E7E8" valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td bgcolor="#E6E7E8" valign="bottom" colspan="5"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td bgcolor="#E6E7E8" valign="bottom">&#xA0;</td> <td bgcolor="#E6E7E8" valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td bgcolor="#E6E7E8" valign="bottom" colspan="5"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td bgcolor="#E6E7E8" valign="bottom">&#xA0;</td> <td bgcolor="#E6E7E8" valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td bgcolor="#E6E7E8" valign="bottom" colspan="5"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: ARIAL" size="1">Derivative Financial Instruments in Cash Flow</font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;Hedge Relationships</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Foreign currency swaps</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$&#xA0;&#xA0;&#xA0;&#x2013;&#x2013;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$&#xA0;&#xA0;&#xA0;&#x2013;&#x2013;&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$&#xA0;&#xA0;&#xA0;&#xA0;(496)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$(1,054)&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$(243)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$(704)&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: ARIAL" size="1">Derivative Financial Instruments in Net Investment</font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;Hedge Relationships</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Foreign currency swaps</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>7</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(1)&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(1,059)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(97)&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2013;&#x2013;&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2013;&#x2013;&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: ARIAL" size="1">Derivative Financial Instruments Not Designated</font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;as Hedges</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Foreign currency forward-exchange contracts</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(260</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(454)&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2013;&#x2013;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2013;&#x2013;&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2013;&#x2013;&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2013;&#x2013;&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Foreign currency swaps</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>106</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">20&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2013;&#x2013;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2013;&#x2013;&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2013;&#x2013;&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2013;&#x2013;&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: ARIAL" size="1">Non-Derivative Financial Instruments in Net</font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;Investment Hedge Relationships</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Foreign currency short-term borrowings</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2013;&#x2013;&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2013;&#x2013;&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>940&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(241)&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2013;&#x2013;&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2013;&#x2013;&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Foreign currency long-term debt</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2013;&#x2013;&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2013;&#x2013;&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(41)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(91)&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2013;&#x2013;&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2013;&#x2013;&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">All other, net</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>15&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(4)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(6)&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>4&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2&#xA0;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="8"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom" colspan="5"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom" colspan="5"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Total</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$(132)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$(434)&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$&#xA0;&#xA0;&#xA0;&#xA0;(660)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$(1,489)&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$(239)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$(702)&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="24"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <!-- End Table Body --></table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">OID = Other (income)/deductions&#x2013;&#x2013;net, included in the income statement account, <i>Other deductions&#x2014;net</i><i>.</i> OCI = <i>Other comprehensive income/(loss)</i><i>,</i> included in the balance sheet account <i>Accumulated other comprehensive loss</i><i>.</i></font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Also includes gains and losses attributable to the hedged risk in fair value hedged relationships.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">There was no significant ineffectiveness for any of the periods presented.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(d)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Amounts presented represent the effective portion of the gain or loss. For derivative financial instruments in cash flow hedge relationships, the effective portion is included in <i>Other comprehensive income/(loss)&#x2013;derivative financial instruments</i>. For derivative financial instruments in net investment hedge relationships and for foreign currency debt designated as hedging instruments, the effective portion is included in <i>Other comprehensive income/(loss)&#x2013;&#x2013;currency translation adjustment and other.</i></font></p> </td> </tr> </table> </div> <div> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><font style="FONT-FAMILY: ARIAL" size="1"><font style="FONT-FAMILY: ARIAL" size="1">The components of our deferred tax assets and liabilities, shown before jurisdictional netting follow:</font></font></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="67%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="16"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: ARIAL" size="1"><b>2011 DEFERRED TAX</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: ARIAL" size="1">2010 DEFERRED TAX</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">(MILLIONS OF DOLLARS)</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom" colspan="2" align="center"> <font style="FONT-FAMILY: ARIAL" size="1"><b>ASSETS</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom" colspan="2" align="center"> <font style="FONT-FAMILY: ARIAL" size="1"><b>(LIABILITIES)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: ARIAL" size="1">ASSETS</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: ARIAL" size="1">(LIABILITIES)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="16"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Prepaid/deferred items</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>$</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,611</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$&#xA0;&#xA0;&#xA0;&#xA0;(211)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,321</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;(112)&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Inventories</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>324</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(52</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">132</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(59)&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Intangibles</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,713</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(16,014</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,165</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(17,104)&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Property, plant and equipment</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>226</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(1,326</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">420</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(2,146)&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Employee benefits</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>4,285</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(524</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">4,479</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(56)&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Restructurings and other charges</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>554</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(95</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,359</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(70)&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Legal and product liability reserves</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,812</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2014;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,411</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Net operating loss/credit carryforwards</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>4,414</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2014;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">4,575</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Unremitted earnings</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2014;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(11,699</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(9,524)&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">State and local tax adjustments</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>476</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2014;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">452</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">All other</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,197</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(125</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">601</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(554)&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="16"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Subtotal</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>16,612</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(30,046</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">15,915</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(29,625)&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Valuation allowance</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(1,201</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2014;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(894</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="16"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Total deferred taxes</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>$</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>15,411</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$(30,046)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">15,021</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$(29,625)&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="16"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Net deferred tax liability<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">,(b)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$(14,635)</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$(14,604)&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="16"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <!-- End Table Body --></table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">2011 vs. 2010 &#x2013; The net deferred tax liability position in 2011 was about the same as 2010 and reflects an increase in noncurrent deferred tax liabilities related to intangibles established in connection with our acquisition of King and an increase in noncurrent deferred tax liabilities on unremitted earnings, partially offset by the reduction in noncurrent deferred tax liabilities related to the amortization of identifiable intangibles, and an increase in current deferred tax assets established as a result of litigation charges related to hormone therapy.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">In 2011, included in <i>Taxes and other current assets</i> ($4.0 billion), <i>Taxes and other noncurrent assets</i> ($1.2 billion), <i>Other current liabilities</i> ($291 million) and <i>Noncurrent deferred tax liabilities</i> ($19.6 billion). In 2010, included in <i>Taxes and other current assets</i> ($3.0 billion), <i>Taxes and other noncurrent assets</i> ($1.2 billion), <i>Other current liabilities</i> ($108 million) and <i>Noncurrent deferred tax liabilities</i> ($18.6 billion).</font></p> </td> </tr> </table> </div> -174000000 0.002 66000000 9112000000 2938000000 <div> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><b><font style="FONT-FAMILY: ARIAL" size="4">17.</font> <font style="FONT-FAMILY: ARIAL" size="2">Commitments and Contingencies</font></b></font></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">We and certain of our subsidiaries are subject to numerous contingencies arising in the ordinary course of business. For a discussion of our tax contingencies, see <i>Note 5D. Taxes on Income: Tax Contingencies</i>.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b><i><u>LEGAL PROCEEDINGS</u></i></b></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Our non-tax contingencies include, among others, the following:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Patent litigation, which typically involves challenges to the coverage and/or validity of our patents on various products or processes. We are the plaintiff in the vast majority of these actions. An adverse outcome in actions in which we are the plaintiff could result in a loss of patent protection for the drug at issue, a significant loss of revenues from that drug and impairments of any associated assets.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Product liability and other product-related litigation, which can include personal injury, consumer, off-label promotion, securities-law, antitrust and breach of contract claims, among others, often involves highly complex issues relating to medical causation, label warnings and reliance on those warnings, scientific evidence and findings, actual provable injury and other matters.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Commercial and other litigation, which can include merger-related and product-pricing claims and environmental claims and proceedings, can involve complexities that will vary from matter to matter.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Government investigations, which often are related to the extensive regulation of pharmaceutical companies by national, state and local government agencies in the U.S. and in other countries.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Certain of these contingencies could result in losses, including damages, fines and/or civil penalties, and/or criminal charges, which could be substantial.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">We believe that our claims and defenses in these matters are substantial, but litigation is inherently unpredictable and excessive verdicts do occur. We do not believe that any of these matters will have a material adverse effect on our financial position. However, we could incur judgments, enter into settlements or revise our expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on our results of operations or cash flows in the period in which the amounts are paid and/or accrued.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">We have accrued for losses that are both probable and reasonably estimable. Substantially all of these contingencies are subject to significant uncertainties and, therefore, determining the likelihood of a loss and/or the measurement of any loss can be complex. Consequently, we are unable to estimate the range of reasonably possible loss in excess of amounts accrued. Our assessments are based on estimates and assumptions that have been deemed reasonable by management, but the assessment process relies heavily on estimates and assumptions that may prove to be incomplete or inaccurate, and unanticipated events and circumstances may occur that might cause us to change those estimates and assumptions.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Amounts recorded for legal and environmental contingencies can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions. For information about the risks associated with estimates and assumptions, see <i>Note 1C. Significant Accounting Policies: Estimates and Assumptions.</i></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">The principal pending matters to which we are a party are discussed below. In determining whether a pending matter is a principal matter, we consider both quantitative and qualitative factors in order to assess materiality, such as, among other things, the amount of damages and the nature of any other relief sought in the proceeding, if such damages and other relief are specified; our view of the merits of the claims and of the strength of our defenses; whether the action purports to be a class action and our view of the likelihood that a class will be certified by the court; the jurisdiction in which the proceeding is pending; any experience that we or, to our knowledge, other companies have had in similar proceedings; whether disclosure of the action would be important to a reader of our financial statements, including whether disclosure might change a reader&#x2019;s judgment about our financial statements in light of all of the information about the Company that is available to the reader; the potential impact of the proceeding on our reputation; and the extent of public interest in the matter. In addition, with respect to patent matters, we consider, among other things, the financial significance of the product protected by the patent. As a result of considering qualitative factors in our determination of principal matters, there are some matters discussed below with respect to which management believes that the likelihood of possible loss in excess of amounts accrued is remote.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="2"><b>A.</b></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="2"><b>Patent Litigation</b></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Like other pharmaceutical companies, we are involved in numerous suits relating to our patents, including but not limited to those discussed below. Most of the suits involve claims by generic drug manufacturers that patents covering our products, processes or dosage forms are invalid and/or do not cover the product of the generic manufacturer. Also, counterclaims, as well as various independent actions, have been filed claiming that our assertions of, or attempts to enforce, our patent rights with respect to certain products constitute unfair competition and/or violations of the antitrust laws. In addition to the challenges to the U.S. patents on a number of our products that are discussed below, we note that the patent rights to certain of our products are being challenged in various other countries.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><i>ACTIONS IN WHICH WE ARE THE PLAINTIFF AND CERTAIN RELATED ACTIONS</i></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Lipitor (atorvastatin)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In November 2008, Apotex Inc. notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Lipitor. In December 2008, we filed patent-infringement suits against Apotex Inc. in the U.S. District Court for the District of Delaware and the U.S. District Court for the Northern District of Illinois. In August 2009, our action in the District of Delaware was transferred to the Northern District of Illinois and consolidated with our pending action there. Apotex Inc. asserts the invalidity of our patent covering the crystalline form of atorvastatin, which (including the six-month pediatric exclusivity period) expires in 2017. We assert the infringement of our crystalline patent and are defending against the allegations of invalidity.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In November 2011, our previously reported patent-infringement actions related to Lipitor against KUDCO Ireland, Ltd. and Kremers Urban LLC and against Aurobindo Pharma Ltd. in the U.S. District Court for the District of Delaware were settled on terms that are not material to Pfizer.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Lipitor began to face generic competition in the U.S. in November 2011.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In the U.K., while the basic patent for Lipitor expired in November 2011, the exclusivity period has been extended by six months to May 2012 by virtue of the supplementary protection certificate and pediatric extension. In September 2011, Dr.&#xA0;Reddy&#x2019;s Laboratories (UK) Limited filed an action in the High Court of Justice seeking revocation of the six-month pediatric extension. We are defending this action, which is based upon the interpretation of the EU Pediatric Medicines Regulation.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Caduet (atorvastatin/amlodipine combination)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In December 2011, our previously reported patent-infringement action related to Caduet against Sandoz, Inc., a division of Novartis AG (Sandoz), in the U.S. District Court for the District of Delaware was voluntarily dismissed by us.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Caduet began to face generic competition in the U.S. in November 2011.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Viagra (sildenafil)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In March 2010, we brought a patent-infringement action in the U.S. District Court for the Eastern District of Virginia against Teva Pharmaceuticals USA, Inc. (Teva USA) and Teva Pharmaceutical Industries Ltd. (Teva Pharmaceutical Industries), which had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Viagra. Teva USA and Teva Pharmaceutical Industries assert the invalidity and non-infringement of the Viagra use patent, which expires in 2019, but have not challenged the basic patent, which expires in 2012. In August 2011, the court ruled that our Viagra use patent is valid and infringed, thereby preventing Teva USA and Teva Pharmaceutical Industries from receiving approval for a generic version of Viagra before October 2019. In September 2011, Teva USA and Teva Pharmaceutical Industries appealed the decision to the U.S. Court of Appeals for the Federal Circuit.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In October 2010, we filed a patent-infringement action with respect to Viagra in the U.S. District Court for the Southern District of New York against Apotex Inc. and Apotex Corp., Mylan Pharmaceuticals Inc. and Mylan Inc., Actavis, Inc. and Amneal Pharmaceuticals LLC. These generic manufacturers have filed abbreviated new drug applications with the FDA seeking approval to market their generic versions of Viagra. They assert the invalidity and non-infringement of the Viagra use patent, but have not challenged the basic patent.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In May and June 2011, respectively, Watson Laboratories Inc. (Watson) and Hetero Labs Limited (Hetero) notified us that they had filed abbreviated new drug applications with the FDA seeking approval to market their generic versions of Viagra. Each asserts the invalidity and non-infringement of the Viagra use patent. Neither has challenged the basic patent. In June and July 2011, respectively, we filed actions against Watson and Hetero in the U.S. District Court for the Southern District of New York asserting the validity and infringement of the use patent.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Sutent (sunitinib malate)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In May 2010, Mylan Pharmaceuticals Inc. notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Sutent and challenging on various grounds the Sutent basic patent, which expires in 2021, and two other patents, which expire in 2020 and 2021. In June 2010, we filed suit against Mylan Pharmaceuticals Inc. in the U.S. District Court for the District of Delaware asserting the infringement of those three patents.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Detrol and Detrol LA (tolterodine)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In January 2008, Impax Laboratories, Inc. (Impax) notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Detrol LA. Impax is challenging on various grounds the basic patent, which (including the six-month pediatric exclusivity period) expires in 2012, and three formulation patents, which (including the six-month pediatric exclusivity period) expire in 2020. We filed an action against Impax in the U.S. District Court for the Southern District of New York asserting the infringement of the basic patent and two of the formulation patents. This action subsequently was transferred to the U.S. District Court for the District of New Jersey.</font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In March 2008 and May 2010, respectively, Sandoz and Mylan Pharmaceuticals Inc. notified us that they had filed abbreviated new drug applications with the FDA seeking approval to market generic versions of Detrol LA. They assert the invalidity and/or non-infringement of three formulation patents for Detrol LA. They have not challenged the basic patent. In June 2010, we filed actions against Sandoz and Mylan Pharmaceuticals Inc. in the U.S. District Court for the District of New Jersey asserting the infringement of two of the formulation patents.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In April 2011, Impax notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Detrol. Impax asserts the non-infringement of the basic patent, which (including the six-month pediatric exclusivity period) expires in 2012. In June 2011, we filed an action against Impax in the U.S. District Court for the District of New Jersey asserting infringement of the basic patent.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In June 2011, Torrent Pharmaceuticals Ltd. (Torrent) notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Detrol LA. Torrent asserted the invalidity and non-infringement of three formulation patents. Torrent did not challenge the basic patent. In July 2011, we filed an action against Torrent in the U.S. District Court for the District of New Jersey asserting the validity and infringement of the challenged patents. In February 2012, this action was settled on terms that are not material to Pfizer.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Lyrica (pregabalin)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Beginning in March 2009, several generic manufacturers notified us that they had filed abbreviated new drug applications with the FDA seeking approval to market generic versions of Lyrica capsules and, in the case of one generic manufacturer, Lyrica oral solution. Each of the generic manufacturers is challenging one or more of three patents for Lyrica: the basic patent, which expires in 2018, and two other patents, which expire in 2013 and 2018. Each of the generic manufacturers asserts the invalidity and/or the non-infringement of the patents subject to challenge. Beginning in April 2009, we filed actions against these generic manufacturers in the U.S. District Court for the District of Delaware asserting the infringement and validity of our patents for Lyrica. All of these cases have been consolidated in the District of Delaware.</font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In November 2010, Novel Laboratories, Inc. (Novel) notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Lyrica oral solution and asserting the invalidity and/or infringement of our three patents for Lyrica referred to above. In January 2011, we filed an action against Novel in the U.S. District Court for the District of Delaware asserting the validity and infringement of all three patents.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Apotex Inc. notified us, in May and June 2011, respectively, that it had filed abbreviated new drug applications with the FDA seeking approval to market generic versions of Lyrica oral solution and Lyrica capsules. Apotex Inc. asserts the invalidity and non-infringement of the basic patent, as well as the seizure patent that expires in 2013. In July 2011, we filed an action against Apotex Inc. in the U.S. District Court for the District of Delaware asserting the validity and infringement of the challenged patents in connection with both of the abbreviated new drug applications.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In October 2011, Alembic Pharmaceuticals Limited (Alembic) notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Lyrica capsules and asserting the invalidity of the basic patent. In December 2011, we filed an action against Alembic in the U.S. District Court for the District of Delaware asserting the validity and infringement of the basic patent.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">We also have filed patent-infringement actions in Canada against certain generic manufacturers who are seeking approval to market generic versions of Lyrica capsules in that country.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Zyvox (linezolid)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In December 2009, Teva Parenteral Medicines Inc. (Teva Parenteral) notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Zyvox. Teva Parenteral asserts the invalidity and non-infringement of the basic Zyvox patent, which (including the six-month pediatric exclusivity period) expires in 2015, and another patent that expires in 2021. In January 2010, we filed suit against Teva Parenteral in the U.S. District Court for the District of Delaware asserting the infringement of the basic patent.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Relpax (eletriptan)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In June 2010, we received notices from Apotex Inc. and Apotex Corp. and from Teva USA that they had filed abbreviated new drug applications with the FDA seeking approval to market generic versions of Relpax. They asserted the non-infringement of our patent covering the crystalline form of eletriptan, which expires in 2017. They did not challenge the basic patent, which expires in 2016. In July 2010, we filed actions against Apotex Inc. and Apotex Corp. and against Teva USA in the U.S. District Court for the Southern District of New York asserting the infringement of the crystalline patent. In July 2011, the action against Teva USA was settled on terms that are not material to Pfizer. In October 2011, the action against Apotex Inc. and Apotex Corp. was voluntarily dismissed by the parties without prejudice.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Protonix (pantoprazole sodium)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Wyeth has a license to market Protonix in the U.S. from Nycomed GmbH (Nycomed), which owns the patents relating to Protonix. The basic patent (including the six-month pediatric exclusivity period) for Protonix expired in January 2011.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Following their respective filings of abbreviated new drug applications with the FDA, Teva USA and Teva Pharmaceutical Industries, Sun Pharmaceutical Advanced Research Centre Ltd. and Sun Pharmaceutical Industries Ltd. (collectively, Sun) and KUDCO Ireland, Ltd. (KUDCO Ireland) received final FDA approval to market their generic versions of Protonix 20mg and 40mg delayed-release tablets. Wyeth and Nycomed filed actions against those generic manufacturers in the U.S. District Court for the District of New Jersey, which subsequently were consolidated into a single proceeding, alleging infringement of the basic patent and seeking declaratory and injunctive relief. Following the court&#x2019;s denial of a preliminary injunction sought by Wyeth and Nycomed, Teva USA and Teva Pharmaceutical Industries and Sun launched their generic versions of Protonix tablets at risk in December 2007 and January 2008, respectively. Wyeth launched its own generic version of Protonix tablets in January 2008, and Wyeth and Nycomed filed amended complaints in the pending patent-infringement action seeking compensation for damages resulting from Teva USA&#x2019;s, Teva Pharmaceutical Industries&#x2019; and Sun&#x2019;s at-risk launches.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In April 2010, the jury in the pending patent-infringement action upheld the validity of the basic patent for Protonix. In July 2010, the court upheld the jury verdict, but it did not issue a judgment against Teva USA, Teva Pharmaceutical Industries or Sun because of their other claims relating to the patent that still are pending. Wyeth and Nycomed will continue to pursue all available legal remedies against those generic manufacturers, including compensation for damages resulting from their at-risk launches.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Separately, Wyeth and Nycomed are defendants in purported class actions brought by direct and indirect purchasers of Protonix in the U.S. District Court for the District of New Jersey. Plaintiffs seek damages, on behalf of the respective putative classes, for the alleged violation of antitrust laws in connection with the procurement and enforcement of the patents for Protonix. These purported class actions have been stayed pending resolution of the underlying patent litigation in the U.S. District Court for the District of New Jersey.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Rapamune (sirolimus)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In March 2010, Watson and Ranbaxy Laboratories Limited (Ranbaxy) notified us that they had filed abbreviated new drug applications with the FDA seeking approval to market generic versions of Rapamune. Watson and Ranbaxy assert the invalidity and non-infringement of a method-of-use patent which (including the six-month pediatric exclusivity period) expires in 2014 and a solid-dosage formulation patent which (including the six-month pediatric exclusivity period) expires in 2018. In April 2010, we filed actions against Watson and Ranbaxy in the U.S. District Court for the District of Delaware and against Watson in the U.S. District Court for the Southern District of Florida asserting the infringement of the method-of-use patent. In June 2010, our action in the Southern District of Florida was transferred to the District of Delaware and consolidated with our pending action there.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Tygacil (tigecycline)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In October 2009, Sandoz notified Wyeth that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Tygacil. Sandoz asserts the invalidity and non-infringement of two of Wyeth&#x2019;s patents relating to Tygacil, including the basic patent, which expires in 2016. In December 2009, Wyeth filed suit against Sandoz in the U.S. District Court for the District of Delaware asserting infringement of the basic patent.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Avinza (morphine sulfate)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">King Pharmaceuticals, Inc. (King) and Elan Pharma International LTD (EPI) brought a patent-infringement action in the U.S. District Court for the District of New Jersey against Sandoz in July 2009 as the result of its abbreviated new drug application with the FDA seeking approval to market a generic version of Avinza. Sandoz is challenging a formulation patent for Avinza, which is owned by EPI, that expires in 2017.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>EpiPen</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">King brought patent-infringement actions against Sandoz in the U.S District Court for the District of New Jersey in July 2010 and against Teva Pharmaceutical Industries and Intelliject, Inc. (Intelliject) in the U.S. District Court for the District of Delaware in August 2009 and January 2011, respectively, as the result of their abbreviated new drug applications with the FDA seeking approval to market epinephrine injectable products. The two actions in Delaware subsequently were consolidated. Sandoz and Teva Pharmaceutical Industries are challenging and Intelliject challenged two patents, which expire in 2025, covering the next generation autoinjector for use with epinephrine that is sold under the EpiPen brand name. In February 2012, the action against Intelliject was settled. Under the settlement agreement, Intellject may launch its epinephrine injectable product no earlier than November&#xA0;15, 2012, subject to final approval by the FDA.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Embeda (morphine sulfate/naltrexone hydrochloride extended-release capsules)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In August 2011, Watson Laboratories Inc. &#x2013; Florida (Watson Florida) notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Embeda extended-release capsules. Watson Florida asserts the invalidity and non-infringement of three formulation patents that expire in 2027. In October 2011, we filed an action against Watson Florida in the U.S. District Court for the District of Delaware asserting the infringement of, and defending against the allegations of the invalidity of, the three formulation patents.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Torisel (temsirolimus)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In November 2011, Sandoz and Accord Healthcare, Inc. USA and certain of its affiliates (collectively, Accord) notified us that they had filed abbreviated new drug applications with the FDA seeking approval to market generic versions of Torisel. Sandoz and Accord assert the invalidity and non-infringement of two patents for Torisel, including the basic patent, which expires in 2014. In December 2011, we filed suit against Sandoz and Accord in the U.S. District Court for the District of Delaware asserting the infringement of, and defending against the allegation of the invalidity of, the basic patent.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><i>ACTION IN WHICH WE ARE THE DEFENDANT AND A RELATED ACTION</i></font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>ReFacto AF and Xyntha</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In February 2008, Novartis Vaccines and Diagnostics, Inc. (Novartis) filed suit against Wyeth and a subsidiary of Wyeth in the U.S. District Court for the Eastern District of Texas alleging that Wyeth&#x2019;s ReFacto AF and Xyntha products infringe two Novartis patents. Novartis&#x2019;s complaint seeks damages, including treble damages, for alleged willful infringement. Wyeth and its subsidiary assert, among other things, the invalidity and non-infringement of the Novartis patents. In November 2009, Novartis added a third patent to its infringement claim against Wyeth and its subsidiary. In August 2010, Novartis granted Wyeth and its subsidiary a covenant not to sue on the third patent and withdrew that patent from its pending action.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In May 2008, a subsidiary of Wyeth filed suit in the U.S. District Court for the District of Delaware against Novartis seeking a&#xA0;declaration that the two Novartis patents initially asserted against Wyeth and its subsidiary in the action referred to in the preceding paragraph are invalid on the ground that the Wyeth subsidiary was the first to invent the subject matter. In February 2010, the District of Delaware declined to invalidate those two Novartis patents. In March 2010, the Wyeth subsidiary appealed the decision to the U.S. Court of Appeals for the Federal Circuit. In August 2011, the Federal Circuit affirmed the District Court&#x2019;s decision. In November 2011, the Federal Circuit denied the Wyeth subsidiary&#x2019;s petition for a rehearing. The Federal Circuit&#x2019;s decision does not address the defenses that Wyeth and its subsidiary are asserting in the action referred to in the previous paragraph.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="2"><b>B.</b></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="2"><b>Product Litigation</b></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Like other pharmaceutical companies, we are defendants in numerous cases, including but not limited to those discussed below, related to our pharmaceutical and other products. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Asbestos</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>&#x2022;&#xA0;&#xA0;</i></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Quigley</i></font></td> </tr> </table> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Quigley Company, Inc. (Quigley), a wholly owned subsidiary, was acquired by Pfizer in 1968 and sold products containing small amounts of asbestos until the early 1970s. In September 2004, Pfizer and Quigley took steps that were intended to resolve all pending and future claims against Pfizer and Quigley in which the claimants allege personal injury from exposure to Quigley products containing asbestos, silica or mixed dust. We recorded a charge of $369 million pre-tax ($229 million after-tax) in the third quarter of 2004 in connection with these matters.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In September 2004, Quigley filed a petition in the U.S. Bankruptcy Court for the Southern District of New York seeking reorganization under Chapter 11 of the U.S. Bankruptcy Code. In March 2005, Quigley filed a reorganization plan in the Bankruptcy Court that needed the approval of 75% of the voting claimants, as well as the Bankruptcy Court and the U.S. District Court for the Southern District of New York. In connection with that filing, Pfizer entered into settlement agreements with lawyers representing more than 80% of the individuals with claims related to Quigley products against Quigley and Pfizer. The agreements provide for a total of $430 million in payments, of which $215 million became due in December 2005 and has been and is being paid to claimants upon receipt by the Company of certain required documentation from each of the claimants. The reorganization plan provided for the establishment of a Trust (the Trust) for the evaluation and, as appropriate, payment of all unsettled pending claims, as well as any future claims alleging injury from exposure to Quigley products.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In February 2008, the Bankruptcy Court authorized Quigley to solicit an amended reorganization plan for acceptance by claimants. According to the official report filed with the court by the balloting agent in July 2008, the requisite votes were cast in favor of the amended plan of reorganization.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">The Bankruptcy Court held a confirmation hearing with respect to Quigley&#x2019;s amended plan of reorganization that concluded in December 2009. In September 2010, the Bankruptcy Court declined to confirm the amended reorganization plan. As a result of the foregoing, Pfizer recorded additional charges for this matter of approximately $1.3 billion pre-tax (approximately $800 million after-tax) in 2010. Further, in order to preserve its right to address certain legal issues raised in the court&#x2019;s opinion, in October 2010, Pfizer filed a notice of appeal and motion for leave to appeal the Bankruptcy Court&#x2019;s decision denying confirmation.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In March 2011, Pfizer entered into a settlement agreement with a committee (the Ad Hoc Committee) representing approximately 40,000 claimants in the Quigley bankruptcy proceeding (the Ad Hoc Committee claimants). Consistent with the additional charges recorded in 2010 referred to above, the principal provisions of the settlement agreement provide for a settlement payment in two installments and other consideration, as follows:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">the payment to the Ad Hoc Committee, for the benefit of the Ad Hoc Committee claimants, of a first installment of $500 million upon receipt by Pfizer of releases of asbestos-related claims against Pfizer Inc. from Ad Hoc Committee claimants holding $500 million in the aggregate of claims (Pfizer began paying this first installment in June 2011);</font></td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">the payment to the Ad Hoc Committee, for the benefit of the Ad Hoc Committee claimants, of a second installment of $300 million upon Pfizer&#x2019;s receipt of releases of asbestos-related claims against Pfizer Inc. from Ad Hoc Committee claimants holding an additional $300 million in the aggregate of claims following the earlier of the effective date of a revised plan of reorganization and April&#xA0;6, 2013;</font></td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">the payment of the Ad Hoc Committee&#x2019;s legal fees and expenses incurred in this matter up to a maximum of $19 million (Pfizer began paying these legal fees and expenses in May 2011); and</font></td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">the procurement by Pfizer of insurance for the benefit of certain Ad Hoc Committee claimants to the extent such claimants with non-malignant diseases have a future disease progression to a malignant disease (Pfizer procured this insurance in August 2011).</font></td> </tr> </table> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Following the execution of the settlement agreement with the Ad Hoc Committee, Quigley filed a revised plan of reorganization and accompanying disclosure statement with the Bankruptcy Court in April 2011. Under the revised plan, and consistent with the additional charges recorded in 2010 referred to above, we expect to contribute an additional amount to the Trust, if and when the Bankruptcy Court confirms the plan, of cash and non-cash assets (including insurance proceeds) with a value in excess of $550 million. The Bankruptcy Court must find that the revised plan meets the requisite standards of the U.S. Bankruptcy Code before it confirms the plan. We expect that, if approved by claimants, confirmed by the Bankruptcy Court and the District Court and upheld on any subsequent appeal, the revised reorganization plan will result in the District Court entering a permanent injunction directing pending claims, as well as future claims, alleging personal injury from exposure to Quigley products to the Trust. There is no assurance that the plan will be confirmed by the courts.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In a separately negotiated transaction with an insurance company in August 2004, we agreed to a settlement related to certain insurance coverage which provides for payments to an insurance proceeds trust established by Pfizer and Quigley over a ten-year period of amounts totaling $405 million. Most of these insurance proceeds, as well as other payments from insurers that issued policies covering Pfizer and Quigley, would be paid, following confirmation, to the Trust for the benefit of present unsettled and future claimants with claims arising from exposure to Quigley products.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;<i>&#xA0;</i></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Other Matters</i></font></td> </tr> </table> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Between 1967 and 1982, Warner-Lambert owned American Optical Corporation, which manufactured and sold respiratory protective devices and asbestos safety clothing. In connection with the sale of American Optical in 1982, Warner-Lambert agreed to indemnify the purchaser for certain liabilities, including certain asbestos-related and other claims. As of December&#xA0;31, 2011, approximately 67,700 claims naming American Optical and numerous other defendants were pending in various federal and state courts seeking damages for alleged personal injury from exposure to asbestos and other allegedly hazardous materials. Warner-Lambert is actively engaged in the defense of, and will continue to explore various means to resolve, these claims.</font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Warner-Lambert and American Optical brought suit in state court in New Jersey against the insurance carriers that provided coverage for the asbestos and other allegedly hazardous materials claims related to American Optical. A majority of the carriers subsequently agreed to pay for a portion of the costs of defending and resolving those claims. The litigation continues against the carriers who have disputed coverage or how costs should be allocated to their policies, and the court held that Warner-Lambert and American Optical are entitled to payment from each of those carriers of a proportionate share of the costs associated with those claims. Under New Jersey law, a special allocation master was appointed to implement certain aspects of the court&#x2019;s rulings.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> &#xA0;</p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Numerous lawsuits are pending against Pfizer in various federal and state courts seeking damages for alleged personal injury from exposure to products containing asbestos and other allegedly hazardous materials sold by Gibsonburg Lime Products Company (Gibsonburg). Gibsonburg was acquired by Pfizer in the 1960s and sold products containing small amounts of asbestos until the early 1970s.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">There also is a small number of lawsuits pending in various federal and state courts seeking damages for alleged exposure to asbestos in facilities owned or formerly owned by Pfizer or its subsidiaries.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Celebrex and Bextra</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Securities and ERISA Actions</i></font></td> </tr> </table> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Beginning in late 2004, actions, including purported class actions, were filed in various federal and state courts against Pfizer, Pharmacia Corporation (Pharmacia) and certain current and former officers, directors and employees of Pfizer and Pharmacia. These actions include (i)&#xA0;purported class actions alleging that Pfizer and certain current and former officers of Pfizer violated federal securities laws by misrepresenting the safety of Celebrex and Bextra, and (ii)&#xA0;purported class actions filed by persons who claim to be participants in the Pfizer or Pharmacia Savings Plan alleging that Pfizer and certain current and former officers, directors and employees of Pfizer or, where applicable, Pharmacia and certain former officers, directors and employees of Pharmacia, violated certain provisions of the Employee Retirement Income Security Act of 1974 (ERISA) by selecting and maintaining Pfizer stock or Pharmacia stock as an investment alternative when it allegedly no longer was a suitable or prudent investment option. In June 2005, the federal securities and ERISA actions were transferred for consolidated pre-trial proceedings to a Multi-District Litigation (In re Pfizer Inc. Securities, Derivative and &#x201C;ERISA&#x201D; Litigation MDL-1688) in the U.S. District Court for the Southern District of New York.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Securities Action in New Jersey</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In 2003, several purported class action complaints were filed in the U.S. District Court for the District of New Jersey against Pharmacia, Pfizer and certain former officers of Pharmacia. The plaintiffs seek damages, alleging that the defendants violated federal securities laws by misrepresenting the data from a study concerning the gastrointestinal effects of Celebrex. These cases were consolidated for pre-trial proceedings in the District of New Jersey (Alaska Electrical Pension Fund et al. v. Pharmacia Corporation et al.). In January 2007, the court certified a class consisting of all persons who purchased Pharmacia securities from April&#xA0;17, 2000 through February&#xA0;6, 2001 and were damaged as a result of the decline in the price of Pharmacia&#x2019;s securities allegedly attributable to the misrepresentations.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In October 2007, the court granted defendants&#x2019; motion for summary judgment and dismissed the plaintiffs&#x2019; claims. In November 2007, the plaintiffs appealed the decision to the U.S. Court of Appeals for the Third Circuit. In January 2009, the Third Circuit vacated the District Court&#x2019;s grant of summary judgment in favor of defendants and remanded the case to the District Court for further proceedings. The Third Circuit also held that the District Court erred in determining that the class period ended on February&#xA0;6, 2001, and directed that the class period end on August&#xA0;5, 2001. In June 2009, the District Court stayed proceedings in the case pending a determination by the U.S. Supreme Court with regard to defendants&#x2019; petition for certiorari seeking reversal of the Third Circuit&#x2019;s decision. In May 2010, the U.S. Supreme Court denied defendants&#x2019; petition for certiorari, and the case was remanded to the District Court for further proceedings.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Other</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Pfizer and several predecessor and affiliated companies, including Monsanto Company (Monsanto), are defendants in an action brought by Brigham Young University (BYU) and a BYU professor in the U.S. District Court for the District of Utah alleging, among other things, breach by Monsanto of a 1991 research agreement with BYU. Plaintiffs claim that research under that agreement led to the discovery of Celebrex and that, as a result, they are entitled to a share of the profits from Celebrex sales. Plaintiffs seek, among other things, compensatory and punitive damages.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Various Drugs: Off-Label Promotion Actions</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Securities Action</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In May 2010, a purported class action was filed in the U.S. District Court for the Southern District of New York against Pfizer and several of our current and former officers. The complaint alleges that the defendants violated federal securities laws by failing to disclose that Pfizer was engaged in off-label marketing of certain drugs. Plaintiffs seek damages in an unspecified amount.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Actions by Health Care Service Corporation</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In June 2010, Health Care Service Corporation (HCSC), for itself and its affiliates, Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas, filed an action against us in the U.S. District Court for the Eastern District of Texas. In July 2010, HCSC amended its complaint. The complaint, as amended, alleges that we engaged in deceptive marketing activities, including off-label promotion, and the payment of improper remuneration to healthcare professionals with respect to Bextra and Celebrex in violation of, among other things, the federal Racketeer Influenced and Corrupt Organizations (RICO) Act and the Illinois Consumer Fraud Act. In December 2010, this action was transferred to a Multi-District Litigation (In re Celebrex and Bextra Marketing, Sales Practices and Product Liability Litigation MDL-1699) in the U.S. District Court for the Northern District of California. In July 2010, HCSC also filed a separate lawsuit against us in the U.S. District Court for the Eastern District of Texas including substantially similar allegations regarding Geodon, Lyrica and Zyvox. In this latter action, in October 2011, HCSC filed an amended complaint that is substantially similar to the original complaint except that it no longer includes allegations regarding Lyrica or claims under the Illinois Consumer Fraud Act. In both actions, HCSC seeks to recover the amounts that it paid for the specified drugs on behalf of its members in Illinois, New Mexico, Oklahoma, and Texas, as well as treble damages and punitive damages.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Hormone-Replacement Therapy</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Personal Injury and Economic Loss Actions</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Pfizer and certain wholly owned subsidiaries and limited liability companies, including Wyeth and King, along with several other pharmaceutical manufacturers, have been named as defendants in approximately 10,000 actions in various federal and state courts alleging personal injury or economic loss related to the use or purchase of certain estrogen and progestin medications prescribed for women to treat the symptoms of menopause. Although new actions are occasionally filed, the number of new actions was not significant in 2011, and we do not expect a substantial change in the rate of new actions being filed. Plaintiffs in these suits allege a variety of personal injuries, including breast cancer, ovarian cancer, stroke and heart disease. Certain co-defendants in some of these actions have asserted indemnification rights against Pfizer and its affiliated companies. The cases against Pfizer and its affiliated companies involve one or more of the following products, all of which remain approved by the FDA: femhrt (which Pfizer divested in 2003); Activella and Vagifem (which are Novo Nordisk products that were marketed by a Pfizer affiliate from 2000 to 2004); Premarin, Prempro, Aygestin, Cycrin and Premphase (which are legacy Wyeth products); and Provera, Ogen, Depo-Estradiol, Estring and generic MPA (which are legacy Pharmacia&#xA0;&amp; Upjohn products). The federal cases have been transferred for consolidated pre-trial proceedings to a Multi-District Litigation (In re Prempro Products Liability Litigation MDL-1507) in the U.S. District Court for the Eastern District of Arkansas. Certain of the federal cases have been remanded to their respective District Courts for further proceedings including, if necessary, trial.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">This litigation consists of individual actions, a few purported statewide class actions and a purported provincewide class action in Quebec, Canada, a statewide class action in California and a nationwide class action in Canada. In March 2011, in an action against Wyeth seeking the refund of the purchase price paid for Wyeth&#x2019;s hormone-replacement therapy products by individuals in the State of California during the period from January 1995 to January 2003, the U.S. District Court for the Southern District of California certified a class consisting of all individual purchasers of such products in California who actually heard or read Wyeth&#x2019;s alleged misrepresentations regarding such products. This is the only hormone-replacement therapy action to date against Pfizer and its affiliated companies in the U.S. in which a class has been certified. In addition, in August 2011, in an action against Wyeth seeking damages for personal injury, the Supreme Court of British Columbia certified a class consisting of all women who were prescribed Premplus and/or Premarin in combination with progestin in Canada between January&#xA0;1, 1997 and December&#xA0;1, 2003 and who thereafter were diagnosed with breast cancer.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Pfizer and its affiliated companies have prevailed in many of the hormone-replacement therapy actions that have been resolved to date, whether by voluntary dismissal by the plaintiffs, summary judgment, defense verdict or judgment notwithstanding the verdict; a number of these cases have been appealed by the plaintiffs. Certain other hormone-replacement therapy actions have resulted in verdicts for the plaintiffs and have included the award of compensatory and, in some instances, punitive damages; each of these cases has been appealed by Pfizer and/or its affiliated companies. The decisions in a few of the cases that had been appealed by Pfizer and/or its affiliated companies or by the plaintiffs have been upheld by the appellate courts, while several other cases that had been appealed by Pfizer and/or its affiliated companies or by the plaintiffs have been remanded by the appellate courts to their respective trial courts for further proceedings. Trials of additional hormone-replacement therapy actions are underway or scheduled in 2012.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">As of December&#xA0;31, 2011, Pfizer and its affiliated companies had settled, or entered into definitive agreements or agreements-in-principle to settle, approximately 52% of the hormone-replacement therapy actions pending against us and our affiliated companies. We have recorded aggregate charges with respect to those actions, as well as with respect to the actions that have resulted in verdicts against us or our affiliated companies, of $336 million in 2011 and $300 million in prior years. In addition, we have recorded a charge of $359 million in 2011 that provides for the minimum expected costs to resolve all remaining hormone-replacement therapy actions against Pfizer and its affiliated companies, consistent with our current ability to quantify such future costs. The $359 million charge is an estimate and, while we cannot reasonably estimate the range of reasonably possible loss in excess of the amount accrued for these contingencies given the uncertainties inherent in this product liability litigation, as described below, additional charges may be required in the future.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Most of the unresolved actions against Pfizer and/or its affiliated companies have been outstanding for more than five years and could take many more years to resolve. However, opportunistic settlements could occur at any time. The litigation process is time-consuming, as every hormone-replacement action being litigated involves contested issues of medical causation and knowledge of risk. Even though the vast majority of hormone-replacement therapy actions concern breast cancer, the underlying facts (e.g., medical causation, family history, reliance on warnings, physician/patient interaction, analysis of labels, actual provable injury and other critical factors) can differ significantly from action to action, and the process of discovery has not yet begun for a majority of the unresolved actions. Our ability to estimate the range of possible loss in excess of amounts accrued is complicated by these factors. In addition, the hormone-replacement therapy litigation involves fundamental issues of science and medicine that often are uncertain and continue to evolve. Key scientific court rulings may have a significant impact on the litigation as a whole. An integral part of the litigation process involves understanding the evolving science, as well as seeking key scientific rulings. Equally important, the discovery process is lengthy and complex and has not yet begun for a majority of the unresolved actions. Therefore, we may not have sufficient information to determine the percentage of unresolved actions that could be impacted by scientific developments and/or key scientific rulings. Our ability to estimate the range of possible loss in excess of amounts accrued is complicated by these fundamental issues of science and medicine, because we do not know how the science may evolve, how the courts will rule on key motions or which unresolved actions will be impacted by these scientific matters.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Accordingly, we cannot reasonably estimate the range of possible loss in excess of amounts accrued for these contingencies.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Government Inquiries; Action by State of Nevada</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Pfizer and/or its affiliated companies also have received inquiries from various federal and state agencies and officials relating to the marketing of their hormone-replacement products. In November 2008, the State of Nevada filed an action against Pfizer, Pharmacia&#xA0;&amp; Upjohn Company and Wyeth in state court in Nevada alleging that they had engaged in deceptive marketing of their respective hormone-replacement therapy medications in Nevada in violation of the Nevada Deceptive Trade Practices Act. The action seeks monetary relief, including civil penalties and treble damages. In February 2010, the action was dismissed by the court on the grounds that the statute of limitations had expired. In July 2011, the Nevada Supreme Court reversed the dismissal and remanded the case to the district court for further proceedings.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Zoloft and Effexor</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Personal Injury Actions</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">A number of individual lawsuits and multi-plaintiff lawsuits have been filed against us and/or our subsidiaries in various federal and state courts alleging personal injury as a result of the purported ingesting of Zoloft or Effexor.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Antitrust Actions</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Beginning in May 2011, purported class actions were filed in certain federal courts against Wyeth and, in certain of the actions, affiliates of Wyeth and certain other defendants relating to Effexor XR, which is the extended-release formulation of Effexor. The plaintiffs in each of these actions seek to represent a class consisting of all persons in the U.S. and its territories who purchased Effexor XR or generic Effexor XR directly (in certain of the actions) or indirectly (in the other actions) from any of the defendants from June&#xA0;14, 2008 until the time the defendants&#x2019; allegedly unlawful conduct ceased (the Class Period). The plaintiffs allege delay in the launch of generic Effexor XR in the U.S. and its territories, in violation of federal antitrust laws and, in the indirect-purchaser actions, the antitrust, consumer protection and various other laws of certain states, as the result of Wyeth fraudulently obtaining and improperly listing certain patents for Effexor XR, enforcing certain patents for Effexor XR, and entering into litigation settlement agreements with various generic manufacturers with respect to Effexor XR. Each of the actions seeks treble damages on behalf of the putative class for alleged price overcharges for Effexor XR or generic Effexor XR in the U.S. and its territories during the Class Period. All of the purported class actions brought by direct purchasers have been consolidated in the U.S. District Court for the District of New Jersey, and all of the purported class actions brought by indirect purchasers have been separately consolidated in the same court. In addition, a few individual actions are pending in the same court that assert claims and seek relief for the plaintiffs that are substantially similar to the claims asserted and the relief sought in the purported class actions.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Neurontin</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Off-Label Promotion Actions in the U.S.</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">A number of lawsuits, including purported class actions, have been filed against us in various federal and state courts alleging claims arising from the promotion and sale of Neurontin. The plaintiffs in the purported class actions seek to represent nationwide and certain statewide classes consisting of persons, including individuals, health insurers, employee benefit plans and other third-party payers, who purchased or reimbursed patients for the purchase of Neurontin that allegedly was used for indications other than those included in the product labeling approved by the FDA. In 2004, many of the suits pending in federal courts, including individual actions as well as purported class actions, were transferred for consolidated pre-trial proceedings to a Multi-District Litigation (In re Neurontin Marketing, Sales Practices and Product Liability Litigation MDL-1629) in the U.S. District Court for the District of Massachusetts.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In the Multi-District Litigation, in 2009, the court denied the plaintiffs&#x2019; renewed motion for certification of a nationwide class of all consumers and third-party payers who allegedly purchased or reimbursed patients for the purchase of Neurontin for off-label uses from 1994 through 2004. In May 2011, the court denied a motion to reconsider its class certification ruling.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In 2010, the Multi-District Litigation court partially granted the Company&#x2019;s motion for summary judgment, dismissing the claims of all of the proposed class representatives for third-party payers and four of the six proposed class representatives for individual consumers. In June 2011, the plaintiffs whose claims were dismissed appealed both the dismissal and the denial of class certification to the U.S. Court of Appeals for the First Circuit.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Also in the Multi-District Litigation, in February 2011, a third-party payer who was not included in the proposed class action appealed a dismissal order to the U.S. Court of Appeals for the First Circuit.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Plaintiffs are seeking certification of statewide classes of Neurontin purchasers in actions pending in California, Illinois and Oklahoma. State courts in New York, Pennsylvania, Missouri and New Mexico have declined to certify statewide classes of Neurontin purchasers. In November 2011, the plaintiff in the Missouri action and a proposed intervenor appealed the denial of class certification.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In January 2011, the U.S. District Court for the District of Massachusetts entered an order trebling a jury verdict against us in an action by a third-party payer seeking damages for the alleged off-label promotion of Neurontin in violation of the federal Racketeer Influenced and Corrupt Organizations (RICO) Act. The verdict was for $47.4 million, which was subject to automatic trebling to $142.1 million under the RICO Act. In November 2010, the court had entered a separate verdict against us in the amount of $65.4 million, together with prejudgment interest, under California&#x2019;s Unfair Trade Practices law relating to the same alleged conduct, which amount is included within and is not additional to the $142.1 million trebled amount of the jury verdict. In August 2011, we appealed the District Court&#x2019;s judgment to the U.S. Court of Appeals for the First Circuit.</font></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;<i>Personal</i></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Injury Actions in the U.S. and Certain Other Countries</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">A number of individual lawsuits have been filed against us in various U.S. federal and state courts and in certain other countries alleging suicide, attempted suicide and other personal injuries as a result of the purported ingesting of Neurontin. Certain of the U.S. federal actions have been transferred for consolidated pre-trial proceedings to the same Multi-District Litigation referred to in the first paragraph of this section.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In addition, purported class actions have been filed against us in various Canadian provincial courts alleging claims arising from the promotion, sale and labeling of Neurontin and generic gabapentin. In a proceeding pending in Ontario, Canada, the court certified a class consisting of all persons in Canada who purchased and ingested Neurontin prior to August 2004. The plaintiffs claim that Pfizer failed to provide adequate warning of the alleged risks of personal injury associated with Neurontin.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;<i>Antitrust</i></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Action in the U.S.</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In January 2011, in a Multi-District Litigation (In re Neurontin Antitrust Litigation MDL-1479) that consolidates four actions, the U.S. District Court for the District of New Jersey certified a nationwide class consisting of wholesalers and other&#xA0;entities who purchased&#xA0;Neurontin directly from Pfizer and Warner-Lambert during the period from&#xA0;December 11, 2002 to August&#xA0;31, 2008 and who also purchased generic gabapentin after it became available. The complaints allege that Pfizer and Warner-Lambert engaged in anticompetitive conduct in violation of the Sherman Act that included, among other things, submitting patents for listing in the Orange Book and prosecuting and enforcing certain patents relating to Neurontin, as well as engaging in off-label marketing of Neurontin. Plaintiffs seek compensatory damages, which may be subject to trebling.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Lipitor</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;<i>Whistleblower</i></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Action</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In 2004, a former employee filed a &#x201C;whistleblower&#x201D; action against us in the U.S. District Court for the Eastern District of New York. The complaint remained under seal until September 2007, at which time the U.S. Attorney for the Eastern District of New York declined to intervene in the case. We were served with the complaint in December 2007. Plaintiff alleges off-label promotion of Lipitor in violation of the Federal Civil False Claims Act and the false claims acts of certain states, and he seeks treble damages and civil penalties on behalf of the federal government and the specified states as the result of their purchase, or reimbursement of patients for the purchase, of Lipitor allegedly for such off-label uses. Plaintiff also seeks compensation as a whistleblower under those federal and state statutes. In addition, plaintiff alleges that he was wrongfully terminated, in violation of the anti-retaliation provisions of applicable federal and New York law, and he seeks damages and the reinstatement of his employment. In 2009, the court dismissed without prejudice the off-label promotion claims and, in 2010, plaintiff filed an amended complaint containing off-label promotion allegations that are substantially similar to the allegations in the original complaint.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;<i>Antitrust</i></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><i>Actions</i></font></td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Beginning in November 2011, purported class actions relating to Lipitor were filed in various federal and state courts against Pfizer, certain affiliates of Pfizer, and, in most of the actions, Ranbaxy, among others. The plaintiffs seek to represent nationwide or statewide classes consisting of persons or entities who directly purchased, indirectly purchased or reimbursed patients for the purchase of Lipitor (or, in certain of the actions, generic Lipitor) from any of the defendants from March 2010 until the cessation of the defendants&#x2019; allegedly unlawful conduct (the Class Period). The plaintiffs allege delay in the launch of generic Lipitor, in violation of federal antitrust laws and/or state antitrust, consumer protection and various other laws resulting from (i)&#xA0;the 2008 agreement pursuant to which Pfizer and Ranbaxy settled certain patent litigation involving Lipitor, and Pfizer granted Ranbaxy a license to sell a generic version of Lipitor in various markets beginning on varying dates, and (ii)&#xA0;in certain of the federal actions, the procurement and/or enforcement of certain patents for Lipitor. Each of the actions seeks, among other things, treble damages on behalf of the putative class for alleged price overcharges for Lipitor (or, in certain of the actions, generic Lipitor) during the Class Period. In addition, an individual action by several California pharmacies was filed in January 2012 in state court in California against Pfizer, Ranbaxy and certain of their affiliates, among others, that asserts claims and seeks relief for the plaintiff pharmacies that are substantially similar to the claims asserted and the relief sought in the purported class actions described above.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Chantix/Champix</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">A number of individual lawsuits have been filed against us in various federal and state courts alleging suicide, attempted suicide and other personal injuries as a result of the purported ingesting of Chantix, as well as economic loss. Plaintiffs in these actions seek compensatory and punitive damages and the disgorgement of profits resulting from the sale of Chantix. In October 2009, the federal cases were transferred for consolidated pre-trial proceedings to a Multi-District Litigation (In re Chantix (Varenicline) Products Liability Litigation MDL-2092) in the U.S. District Court for the Northern District of Alabama.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Beginning in December 2008, purported class actions were filed against us in the Ontario Superior Court of Justice (Toronto Region), the Superior Court of Quebec (District of Montreal), the Court of Queen&#x2019;s Bench of Alberta, Judicial District of Calgary, and the Superior Court of British Columbia (Vancouver Registry) on behalf of all individuals and third-party payers in Canada who have purchased and ingested Champix or reimbursed patients for the purchase of Champix. Each of these actions asserts claims under Canadian product liability law, including with respect to the safety and efficacy of Champix, and, on behalf of the putative class, seeks monetary relief, including punitive damages. The actions in Quebec, Alberta and British Columbia have been stayed pending the decision regarding class certification in the Ontario action.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Bapineuzumab</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In June 2010, a purported class action was filed in the U.S. District Court for the District of New Jersey against Pfizer, as successor to Wyeth, and several former officers of Wyeth. The complaint alleges that Wyeth and the individual defendants violated federal securities laws by making or causing Wyeth to make false and misleading statements, and by failing to disclose or causing Wyeth to fail to disclose material information, concerning the results of a clinical trial involving bapineuzumab, a product in development for the treatment of Alzheimer&#x2019;s disease. The plaintiff seeks to represent a class consisting of all persons who purchased Wyeth securities from May&#xA0;21, 2007 through July 2008 and seeks damages in an unspecified amount on behalf of the putative class. In February 2012, the court granted the defendants&#x2019; motion to dismiss the complaint. The court&#x2019;s decision is subject to possible appeal by the plaintiff.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In July 2010, a related action was filed in the U.S. District Court for the Southern District of New York against Elan Corporation (Elan), certain directors and officers of Elan, and Pfizer, as successor to Wyeth. Elan participated in the development of bapineuzumab until September 2009. The complaint alleges that Elan, Wyeth and the individual defendants&#xA0;violated federal securities laws by making or causing Elan to make false and misleading statements, and by failing to disclose or causing Elan to fail to disclose material information, concerning the results of a clinical trial involving bapineuzumab. The plaintiff seeks to represent a class consisting of all persons who purchased Elan call options from June&#xA0;17, 2008 through July&#xA0;29, 2008 and seeks damages in an unspecified amount on behalf of the putative class. In June 2011, the court granted Pfizer&#x2019;s and Elan&#x2019;s motions to dismiss the complaint. In July 2011, the plaintiff filed a supplemental memorandum setting forth the bases that the plaintiff believed supported amendment of the complaint. In August 2011, the court dismissed the complaint with prejudice. In September 2011, the plaintiff appealed the District Court&#x2019;s decision to the U.S. Court of Appeals for the Second Circuit.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Thimerosal</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Wyeth is a defendant in a number of suits by or on behalf of vaccine recipients alleging that exposure through vaccines to cumulative doses of thimerosal, a preservative used in certain childhood vaccines formerly manufactured and distributed by Wyeth and other vaccine manufacturers, caused severe neurological damage and/or autism in children. While several suits were filed as purported nationwide or statewide class actions, all of the purported class actions have been dismissed, either by the courts or voluntarily by the plaintiffs. In addition to the suits alleging injury from exposure to thimerosal, certain of the cases were brought by parents in their individual capacities for, among other things, loss of services and loss of consortium of the injured child.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">The National Childhood Vaccine Injury Act (the Vaccine Act) requires that persons alleging injury from childhood vaccines first file a petition in the U.S. Court of Federal Claims asserting a vaccine-related injury. At the conclusion of that proceeding, petitioners may bring a lawsuit against the manufacturer in federal or state court, provided that they have satisfied certain procedural requirements. Also under the terms of the Vaccine Act, if a petition has not been adjudicated by the U.S. Court of Federal Claims within a specified time period after filing, the petitioner may opt out of the proceeding and pursue a lawsuit against the manufacturer by following certain procedures. Some of the vaccine recipients who have sued Wyeth to date may not have satisfied the conditions to filing a lawsuit that are mandated by the Vaccine Act. The claims brought by parents for, among other things, loss of services and loss of consortium of the injured child are not covered by the Vaccine Act.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In 2002, the Office of Special Masters of the U.S. Court of Federal Claims established an Omnibus Autism Proceeding with jurisdiction over petitions in which vaccine recipients claim to suffer from autism or autism spectrum disorder as a result of receiving thimerosal-containing childhood vaccines and/or the measles, mumps and rubella (MMR) vaccine. There currently are several thousand petitions pending in the Omnibus Autism Proceeding. Special masters of the court have heard six test cases on petitioners&#x2019; theories that either thimerosal-containing vaccines in combination with the MMR vaccine or thimerosal-containing vaccines alone can cause autism or autism spectrum disorder.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">In February 2009, special masters of the U.S. Court of Federal Claims rejected the three cases brought on the theory that a combination of MMR and thimerosal-containing vaccines caused petitioners&#x2019; conditions. After these rulings were affirmed by the U.S. Court of Federal Claims, two of them were appealed by petitioners to the U.S. Court of Appeals for the Federal Circuit. In 2010, the Federal Circuit affirmed the decisions of the special masters in both of these cases.</font></td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">In March 2010, special masters of the U.S. Court of Federal Claims rejected the three additional test cases brought on the theory that thimerosal-containing vaccines alone caused petitioners&#x2019; conditions. Petitioners did not seek review by the U.S. Court of Federal Claims of the decisions of the special masters in these latter three test cases, and judgments were entered dismissing the cases in April 2010.</font></td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;&#xA0;&#xA0;&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">Petitioners in each of the six test cases have filed an election to bring a civil action.</font></td> </tr> </table> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Pristiq</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In late 2007 and early 2008, the following actions were filed in various federal courts: (i)&#xA0;a purported class action alleging that Wyeth and certain former officers of Wyeth violated federal securities laws by misrepresenting the safety of Pristiq during the period before the FDA&#x2019;s issuance in July 2007 of an &#x201C;approvable letter&#x201D; for Pristiq for the treatment of vasomotor symptoms, which allegedly caused a decline in the price of Wyeth stock; and (ii)&#xA0;a purported class action against Wyeth, the Wyeth Savings Plan Committee, the Wyeth Savings Plan-Puerto Rico Committee, the Wyeth Retirement Committee and certain former Wyeth officers and committee members alleging that they violated certain provisions of ERISA by maintaining Wyeth stock as an investment alternative under certain Wyeth plans notwithstanding their alleged knowledge of the aforementioned alleged misrepresentation.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">The U.S. District Court for the Southern District of New York dismissed the ERISA action and denied the plaintiff&#x2019;s motion to amend the complaint in March and August 2010, respectively. In September 2010, the plaintiff appealed both of those rulings to the U.S. Court of Appeals for the Second Circuit. In November 2010, the plaintiff withdrew the appeal, but has reserved the right to reinstate the appeal by March 2012. The purported securities class action remains pending.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Rebif</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">We have an exclusive collaboration agreement with EMD Serono, Inc. (Serono) to co-promote Rebif, a treatment for multiple sclerosis, in the U.S. In August 2011, Serono filed a complaint in the Philadelphia Court of Common Pleas seeking a declaratory judgment that we are not entitled to a 24-month extension of the Rebif co-promotion agreement, which otherwise would terminate at the end of 2013. We disagree with Serono&#x2019;s interpretation of the agreement and believe that we have the right to extend the agreement to the end of 2015. In October 2011, the court sustained our preliminary objections and dismissed Serono&#x2019;s complaint, and Serono has appealed the decision to the Superior Court of Pennsylvania.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="2"><b>C.</b></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="2"><b>&#xA0;Commercial and Other Matters</b></font></td> </tr> </table> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Acquisition of Wyeth</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In 2009, a number of retail pharmacies in California brought an action against Pfizer and Wyeth in the U.S. District Court for the Northern District of California. The plaintiffs alleged, among other things, that our acquisition of Wyeth violated various federal antitrust laws by creating a monopoly in the manufacture, distribution and sale of prescription drugs in the U.S. In April 2010, the District Court granted our motion to dismiss the second amended complaint. In May 2011, the U.S. Court of Appeals for the Ninth Circuit affirmed the dismissal by the District Court and, in June 2011, it denied plaintiffs&#x2019; petition for a rehearing. In December 2011, the U.S. Supreme Court denied the plaintiffs&#x2019; petition for certiorari seeking reversal of the Ninth Circuit&#x2019;s decision.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Acquisition of King Pharmaceuticals, Inc.</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In October 2010, several purported class action complaints were filed in state court in Tennessee by shareholders of King challenging Pfizer&#x2019;s acquisition of King. King and the individuals who served as the members of King&#x2019;s Board of Directors at the time of the execution of the merger agreement are named as defendants in all of these actions. Pfizer and Parker Tennessee Corp., a subsidiary of Pfizer, also are named as defendants in most of these actions.</font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In November 2010, all of these actions were consolidated in the Chancery Court for Sullivan County, Tennessee Second Judicial District, at Bristol. The parties to the consolidated action have reached an agreement-in-principle to resolve that action as a result of certain disclosures regarding the transaction made by King in its amended Schedule 14D-9 recommendation statement for the tender offer dated January&#xA0;21, 2011. The proposed settlement is subject to, among other things, court approval.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Average Wholesale Price Litigation</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">A number of states, as well as most counties in New York, have sued Pharmacia, Pfizer and other pharmaceutical manufacturers alleging that they provided average wholesale price (AWP) information for certain of their products that was higher than the actual prices at which those products were sold. The AWP is used to determine reimbursement levels under Medicare Part B and Medicaid and in many private-sector insurance policies and medical plans. The plaintiffs claim that the alleged spread between the AWPs at which purchasers were reimbursed and the actual sale prices was promoted by the defendants as an incentive to purchase certain of their products. In addition to suing on their own behalf, many of the plaintiff states seek to recover on behalf of individual Medicare Part B co-payers and private-sector insurance companies and medical plans in their states. These various actions generally assert fraud claims, as well as claims under state deceptive trade practice laws, and seek monetary and other relief, including civil penalties and treble damages. Several of the suits also allege that Pharmacia and/or Pfizer did not report to the states their best price for certain products under the Medicaid program.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In addition, Pharmacia, Pfizer and other pharmaceutical manufacturers are defendants in a number of purported class action suits in various federal and state courts brought by employee benefit plans and other third-party payers that assert claims similar to those in the state and county actions. These suits allege, among other things, fraud, unfair competition and unfair trade practices and seek monetary and other relief, including civil penalties and treble damages.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">All of these state, county and purported class action suits were transferred for consolidated pre-trial proceedings to a Multi-District Litigation (In re Pharmaceutical Industry Average Wholesale Price Litigation MDL-1456) in the U.S. District Court for the District of Massachusetts. Certain of the state and private suits have been remanded to their respective state courts. In 2006, the claims against Pfizer in the Multi-District Litigation were dismissed with prejudice.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In 2008, the court in the Multi-District Litigation granted preliminary approval with respect to the fairness of a proposed settlement of the claims against 11 defendants, including Pharmacia, for a total of $125 million. In December 2011, the court granted final approval of the settlement. Pharmacia&#x2019;s contribution to the settlement was not material to Pfizer.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In addition, Wyeth is a defendant in AWP actions brought by certain states, which are not included in the Multi-District Litigation. Wyeth also is a defendant in a purported class action in state court in New Jersey brought by a union health and welfare plan on behalf of a putative class consisting of third-party payers in New Jersey. In addition, King and/or certain of its subsidiaries are defendants in AWP actions brought by certain states, which are not included in the Multi-District Litigation.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Monsanto-Related Matters</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In 1997, Monsanto Company (Former Monsanto) contributed certain chemical manufacturing operations and facilities to a newly formed corporation, Solutia Inc. (Solutia), and spun off the shares of Solutia. In 2000, Former Monsanto merged with Pharmacia&#xA0;&amp; Upjohn Company to form Pharmacia Corporation (Pharmacia). Pharmacia then transferred its agricultural operations to a newly created subsidiary, named Monsanto Company (New Monsanto), which it spun off in a two-stage process that was completed in 2002. Pharmacia was acquired by Pfizer in 2003 and is now a wholly owned subsidiary of Pfizer.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In connection with its spin-off that was completed in 2002, New Monsanto assumed, and agreed to indemnify Pharmacia for, any liabilities related to Pharmacia&#x2019;s former agricultural business. New Monsanto is defending and indemnifying Pharmacia in connection with various claims and litigation arising out of, or related to, the agricultural business.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In connection with its spin-off in 1997, Solutia assumed, and agreed to indemnify Pharmacia for, liabilities related to Former Monsanto&#x2019;s chemical businesses. As the result of its reorganization under Chapter 11 of the U.S. Bankruptcy Code, Solutia&#x2019;s indemnification obligations related to Former Monsanto&#x2019;s chemical businesses are limited to sites that Solutia has owned or operated. In addition, in connection with its spinoff that was completed in 2002, New Monsanto assumed, and agreed to indemnify Pharmacia for, any liabilities primarily related to Former Monsanto&#x2019;s chemical businesses, including, but not limited to, any such liabilities that Solutia assumed. Solutia&#x2019;s and New Monsanto&#x2019;s assumption of and agreement to indemnify Pharmacia for these liabilities apply to pending actions and any future actions related to Former Monsanto&#x2019;s chemical businesses in which Pharmacia is named as a defendant, including, without limitation, actions asserting environmental claims, including alleged exposure to polychlorinated biphenyls. Solutia and New Monsanto are defending and indemnifying Pharmacia in connection with various claims and litigation arising out of, or related to, Former Monsanto&#x2019;s chemical businesses.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Trade Secrets Action in California</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In 2004, Ischemia Research and Education Foundation (IREF) and its chief executive officer brought an action in California Superior Court, Santa Clara County, against a former IREF employee and Pfizer. Plaintiffs allege that defendants conspired to misappropriate certain information from IREF&#x2019;s allegedly proprietary database in order to assist Pfizer in designing and executing a clinical study of a Pfizer drug. In 2008, the jury returned a verdict for compensatory damages of approximately $38.7 million. In March 2009, the court awarded prejudgment interest, but declined to award punitive damages. In July 2009, the court granted our motion for a new trial and vacated the jury verdict.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Trimegestone</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Aventis filed a breach of contract action against Wyeth in the Commercial Court of Nanterre in France arising out of the December 2003 termination by Wyeth of an October 2000 agreement between Wyeth and Aventis relating to the development of hormone-therapy drugs utilizing Aventis&#x2019;s trimegestone (TMG) progestin. Aventis alleges that the termination was improper and seeks monetary&#xA0;damages. In 2009, a three-judge tribunal rendered its decision in favor of Wyeth. In May 2010, the Versailles Court of Appeals reversed the Commercial Court&#x2019;s decision and appointed experts to hear evidence and make a recommendation to the Court of Appeals concerning damages. In November 2011, the Supreme Court of France affirmed the decision of the Court of Appeals. The damage proceeding by the experts appointed by the Court of Appeals is continuing.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b>Environmental Matters</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In 2009, we submitted to the U.S. Environmental Protection Agency (EPA) a corrective measures study report with regard to Pharmacia Corporation&#x2019;s discontinued industrial chemical facility in North Haven, Connecticut and a revised site-wide feasibility study with regard to Wyeth&#x2019;s discontinued industrial chemical facility in Bound Brook, New Jersey. In September 2010, our corrective measures study report with regard to the North Haven facility was approved by the EPA, and we commenced construction of the site remedy in late 2011 under an Updated Administrative Order on Consent with the EPA. In July 2011, we finalized an Administrative Settlement Agreement and Order on Consent for Removal Action with the EPA with regard to the Bound Brook facility and commenced construction of an interim remedy to address the discharge of impacted groundwater from that facility to the Raritan River. In February 2012, the EPA issued a proposed remediation plan for the Bound Brook facility. The proposed plan, which is subject to public comment, is generally in accordance with one of the remedies evaluated in the Company&#x2019;s revised site-wide feasibility study. The estimated costs of the site remedy for the North Haven facility and the proposed remediation plan for the Bound Brook facility are covered by accruals previously taken by the Company.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px">&#xA0;</p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">We are a party to a number of other proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended (CERCLA or Superfund), and other state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In February 2011, King received notice from the U.S. Department of Justice (DOJ) advising that the EPA has requested that DOJ initiate enforcement action seeking injunctive relief and penalties against King for alleged non-compliance with certain provisions of the federal Clean Air Act at its Bristol, Tennessee manufacturing facility. King has executed a tolling agreement with the DOJ in order to facilitate the possible resolution of this matter.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In October 2011, we voluntarily disclosed to the EPA potential non-compliance with certain provisions of the federal Clean Air Act at our Barceloneta, Puerto Rico manufacturing facility. We do not expect that any penalties that may result from this matter will be material to the Company.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="2"><b>D.</b></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="2"><b>Government Investigations</b></font></td> </tr> </table> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">Like other pharmaceutical companies, we are subject to extensive regulation by national, state and local government agencies in the U.S. and in the other countries in which we operate. As a result, we have interactions with government agencies on an ongoing basis. Among the investigations by government agencies are those discussed below. It is possible that criminal charges and substantial fines and/or civil penalties could result from government investigations, including but not limited to those discussed below.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">The Company has voluntarily provided the DOJ and the U.S. Securities and Exchange Commission (SEC) with information concerning potentially improper payments made by certain Pfizer and Wyeth subsidiaries in connection with certain sales activities outside the U.S. In recent discussions, we have reached agreements-in-principle with the SEC staff and with the DOJ, and we are in the process of finalizing a resolution of these matters. In addition, certain potentially improper payments and other matters are the subject of investigations by government authorities in certain foreign countries. The previously reported investigation in Germany with respect to certain tax matters relating to a wholly owned subsidiary of Pfizer was resolved in December 2011 with no criminal charges and with the payment of an amount, primarily for interest, that was not material to Pfizer.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">The DOJ is conducting civil and criminal investigations regarding Wyeth&#x2019;s promotional practices with respect to Protonix and its practices relating to the pricing for Protonix for Medicaid rebate purposes. In connection with the pricing investigation, in 2009, the DOJ filed a civil complaint in intervention in two qui tam actions that had been filed under seal in the U.S. District Court for the District of Massachusetts. The complaint alleges that Wyeth&#x2019;s practices relating to the pricing for Protonix for Medicaid rebate purposes between 2001 and 2006 violated the Federal Civil False Claims Act and federal common law. The two qui tam actions have been unsealed and the complaints include substantially similar allegations. In addition, in 2009, several states and the District of Columbia filed a complaint under the same docket number asserting violations of various state laws based on allegations substantially similar to those set forth in the civil complaint filed by the DOJ. We are exploring with the DOJ various ways to resolve its civil and criminal investigations relating to Protonix.</font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">The DOJ, including the U.S. Attorney&#x2019;s Office for the Western District of Oklahoma, is conducting a civil and criminal investigation with respect to Wyeth&#x2019;s promotional practices relating to Rapamune. In addition, in October 2010, the DOJ was permitted to intervene in a qui tam action, which alleges off-label promotion of Rapamune, that was pending in the U.S. District Court for the Eastern District of Pennsylvania. In December 2010, the qui tam action was transferred to the Western District of Oklahoma, where it was consolidated with the proceedings underway there. We are exploring with the DOJ various ways to resolve this matter.</font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">We have received civil investigative demands and informal inquiries from the consumer protection divisions of several states seeking information and documents concerning the promotion of Lyrica and Zyvox. We are in discussions with those states regarding a resolution of this matter. These requests appear to relate to the same past promotional practices concerning these products that were the subject of previously reported settlements in September 2009 with the DOJ and the Medicaid fraud control units of various states.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b><i><u>GUARANTEES AND INDEMNIFICATIONS</u></i></b></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">In the ordinary course of business and in connection with the sale of assets and businesses, we often indemnify our counterparties against certain liabilities that may arise in connection with the transaction or related to activities prior to the transaction. These indemnifications typically pertain to environmental, tax, employee and/or product-related matters and patent-infringement claims. If the indemnified party were to make a successful claim pursuant to the terms of the indemnification, we would be required to reimburse the loss. These indemnifications are generally subject to threshold amounts, specified claim periods and other restrictions and limitations. Historically, we have not paid significant amounts under these provisions and, as of December&#xA0;31, 2011, recorded amounts for the estimated fair value of these indemnifications were not significant.</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1"><b><i><u>PURCHASE COMMITMENTS</u></i></b></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="1">As of December&#xA0;31, 2011, we have agreements totaling $3.8 billion to purchase goods and services that are enforceable and legally binding and include amounts relating to advertising, information technology services, employee benefit administration services, and potential milestone payments deemed reasonably likely to occur.</font></p> </div> <div> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><b><font style="FONT-FAMILY: ARIAL" size="4"><font style="FONT-FAMILY: ARIAL" size="2"><b><font style="FONT-FAMILY: ARIAL" size="4">18.</font> <font style="FONT-FAMILY: ARIAL" size="2">Segment, Geographic and Other Revenue Information</font></b></font></font></b></font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><b><font style="FONT-FAMILY: ARIAL" size="2"><b>A. Segment Information</b></font></b></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">We manage our operations through five operating segments&#x2013;&#x2013;Primary Care, Specialty Care and Oncology, Established Products and Emerging Markets, Animal Health and Consumer Healthcare and Nutrition. Each operating segment has responsibility for its commercial activities and for certain research and development activities related to in-line products and IPR&amp;D projects that generally have achieved proof-of-concept. Previously, we managed our operations through two operating segments&#x2013;&#x2013;Biopharmaceutical and Diversified. We have restated our prior period segment information to conform with the current period presentation.</font></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">We regularly review our segments and the approach used by management to evaluate performance and allocate resources.</font></font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1"><u>Operating Segments</u></font></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">A description of each of our five operating segments follows:</font></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Primary Care operating segment&#x2013;&#x2013;includes revenues and earnings, as defined by management, from human pharmaceutical products primarily prescribed by primary-care physicians, and may include products in the following therapeutic and disease areas: Alzheimer&#x2019;s disease, cardiovascular (excluding pulmonary arterial hypertension), erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory and smoking cessation. Examples of products in this unit include Celebrex, Chantix/Champix, Lipitor, Lyrica, Premarin, Pristiq and Viagra. All revenues and earnings for such products are allocated to the Primary Care unit, except those generated in Emerging Markets and those that are managed by the Established Products unit.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Specialty Care and Oncology operating segment&#x2013;&#x2013;comprises the Specialty Care business unit and the Oncology business unit.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="3%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">-</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Specialty Care&#x2013;&#x2013;includes revenues and earnings, as defined by management, from most human pharmaceutical products primarily prescribed by physicians who are specialists, and may include products in the following therapeutic and disease areas: anti-infectives, endocrine disorders, hemophilia, inflammation, multiple sclerosis, ophthalmology, pulmonary arterial hypertension, specialty neuroscience and vaccines. Examples of products in this unit include BeneFIX, Enbrel, Genotropin, Geodon, the Prevnar/Prevenar franchise, Rebif, ReFacto AF, Revatio, Xalatan , Xyntha and Zyvox. All revenues and earnings for such products are allocated to the Specialty Care unit, except those generated in Emerging Markets and those that are managed by the Established Products unit.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="3%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">-</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">Oncology&#x2013;&#x2013;includes revenues and earnings, as defined by management, from human prescription pharmaceutical products addressing oncology and oncology-related illnesses. Examples of products in this unit include Aromasin, Sutent, Torisel and Xalkori. All revenues and earnings for such products are allocated to the Oncology unit, except those generated in Emerging Markets and those that are managed by the Established Products unit.</font></td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Established Products and Emerging Markets operating segment&#x2013;&#x2013;comprises the Established Products business unit and the Emerging Markets business unit.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="3%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">-</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">Established Products&#x2013;&#x2013;generally includes revenues and earnings, as defined by management, from human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions. Typically, products are transferred to this unit in the beginning of the fiscal year following loss of patent protection or marketing exclusivity. In certain situations, products may be transferred to this unit at a different point than the beginning of the fiscal year following loss of patent protection or marketing exclusivity in order to maximize their value. This unit also excludes revenues and earnings generated in Emerging Markets. Examples of products in this unit include Arthrotec, Effexor, Medrol, Norvasc, Protonix, Relpax and Zosyn/Tazocin.</font></td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="3%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">-</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">Emerging Markets&#x2013;&#x2013;includes revenues and earnings, as defined by management, from all human prescription pharmaceutical products sold in Emerging Markets, including Asia (excluding Japan and South Korea), Latin America, Middle East, Africa, Central and Eastern Europe and Turkey.</font></td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Animal Health and Consumer Healthcare operating segment&#x2014;comprises the Animal Health business unit and the Consumer Healthcare business unit.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="3%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">-</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">Animal Health&#x2013;&#x2013;includes worldwide revenues and earnings, as defined by management, from products and services to prevent and treat disease in livestock and companion animals, including vaccines, parasiticides and anti-infectives.</font></td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="3%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">-</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: ARIAL" size="1">Consumer Healthcare&#x2013;&#x2013;generally includes worldwide revenues and earnings, as defined by management, from non-prescription products in the following therapeutic categories: dietary supplements, pain management, respiratory and personal care. Products marketed by Consumer Healthcare include Advil, Caltrate, Centrum, ChapStick, Preparation H and Robitussin.</font></td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Nutrition operating segment&#x2013;&#x2013;generally includes revenues and earnings, as defined by management, from a full line of infant and toddler nutritional products sold outside of the U.S. and Canada.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">Our chief operating decision maker uses the revenues and earnings of the five operating segments, among other factors, for performance evaluation and resource allocation. For the operating segments that comprise more than one business unit, a single segment manager has responsibility for those business units.</font></font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1"><u>Other Costs and Business Activities</u></font></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">Certain costs are not allocated to our operating segment results, such as costs associated with the following:</font></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Worldwide Research and Development (WRD), which is generally responsible for human health research projects until proof-of-concept is achieved and then for transitioning those projects to the appropriate business unit for possible clinical and commercial development. R&amp;D spending may include upfront and milestone payments for intellectual property rights. This organization also has responsibility for certain science-based platform services, which provide technical expertise and other services to the various research and development projects.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Pfizer Medical, which is responsible for all human-health-related regulatory submissions and interactions with regulatory agencies. This organization is also responsible for the collection, evaluation and reporting of all safety event information related to our human health products and for conducting clinical trial audits and readiness reviews and for providing Pfizer-related medical information to healthcare providers.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Corporate, which is responsible for platform functions such as finance, global real estate operations, human resources, legal, compliance, science and technology, worldwide procurement, worldwide public affairs and policy and worldwide technology. These costs also include compensation costs and other miscellaneous operating expenses not charged to our operating segments, as well as interest income and expense.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 8px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: ARIAL" size="1">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Certain transactions and events such as (i)&#xA0;purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory, intangible assets and property, plant and equipment; (ii)&#xA0;acquisition-related activities, where we incur costs for restructuring, integration, implementation and executing the transaction; and (iii)&#xA0;certain significant items, which include non-acquisition-related restructuring costs, as well as costs incurred for legal settlements, asset impairments and sales of assets or businesses.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1"><u>Segment Assets</u></font></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">We manage our assets on a total company basis, not by operating segment, as many of our operating assets are shared (such as our plant network assets) or commingled (such as accounts receivable, as many of our customers are served by multiple operating segments). Therefore, our chief operating decision maker does not regularly review any asset information by operating segment and, accordingly, we do not report asset information by operating segment. Total assets were approximately $188 billion at December&#xA0;31, 2011 and approximately $195 billion at December&#xA0;31, 2010.</font></font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1"><u>Selected Income Statement Information</u></font></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">Selected income statement information follows:</font></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 2px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="86%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">(MILLIONS OF DOLLARS)</font></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: ARIAL" size="1">REVENUES</font></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: ARIAL" size="1">R&amp;D&#xA0;EXPENSES</font></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"> <font style="FONT-FAMILY: ARIAL" size="1">EARNINGS<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup></font></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="center"> <font style="FONT-FAMILY: ARIAL" size="1">DEPRECIATION&#xA0;&amp;</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="center"> <font style="FONT-FAMILY: ARIAL" size="1">AMORTIZATION<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup></font></p> </td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom"><font size="1">&#xA0;</font></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1"><b>YEAR ENDED DECEMBER 31, 2011<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> </tr> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Primary Care</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$22,670</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$1,307</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$15,001</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$&#xA0;&#xA0; 247</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Specialty Care and Oncology</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>16,568</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,561</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>10,789</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>419</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Established Products and Emerging Markets</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>18,509</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>441</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>9,417</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>422</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Animal Health and Consumer Healthcare</b></font></p> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>7,241</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>425</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2,020</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>232</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Total reportable segments</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>64,988</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>3,734</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>37,227</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,320</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Nutrition and other business activities<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(d)</sup></b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2,437</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>3,378</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(2,793</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>230</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Reconciling Items:</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> </tr> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Corporate<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(e)</sup></b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2014;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,309</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(7,430</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>541</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Purchase accounting adjustments<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(f)</sup></b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2014;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(2</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(6,801</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>5,565</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Acquisition-related costs<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(g)</sup></b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2014;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>23</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(1,983</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>624</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Certain significant items<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(h)</sup></b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2014;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>656</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(4,354</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>615</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr> <td bgcolor="#E6E7E8" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Other unallocated<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(i)</sup></b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#x2014;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>14</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>(1,104</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>)&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>131</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="top"><font size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$67,425</b></font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$9,112</b></font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$12,762</b></font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$9,026</b></font></td> <td style="BORDER-TOP: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">YEAR ENDED DECEMBER 31, 2010</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Primary Care</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$23,328</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$1,473</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$15,773</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$201</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Specialty Care and Oncology</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">16,435</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,624</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">10,571</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">432</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Established Products and Emerging Markets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">18,760</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">452</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">10,100</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">418</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Animal Health and Consumer Healthcare</font></p> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">6,347</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">428</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,569</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">197</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Total reportable segments</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">64,870</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">3,977</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">38,013</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,248</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Nutrition and other business activities<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(d)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,187</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">3,743</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(3,263</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">242</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Reconciling Items:</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Corporate<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(e)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,567</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(7,990</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">619</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Purchase accounting adjustments<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(f)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">26</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(8,257</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">5,477</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Acquisition-related costs<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(g)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">34</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(3,989</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">788</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Certain significant items<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(h)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">18</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(3,964</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Other unallocated<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(i)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">27</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(1,268</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">113</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="top"><font size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$67,057</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$9,392</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$9,282</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$8,487</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">YEAR ENDED DECEMBER 31, 2009<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Primary Care</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$22,576</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$1,407</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$15,100</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$130</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Specialty Care and Oncology</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">8,925</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,060</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">4,661</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">269</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Established Products and Emerging Markets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">13,947</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">392</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">6,955</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">360</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Animal Health and Consumer Healthcare</font></p> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">3,258</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">297</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">812</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">142</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Total reportable segments</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">48,706</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">3,156</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">27,528</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">901</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Nutrition and other business activities<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(d)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">563</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,706</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(2,751</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">181</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Reconciling Items:</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Corporate<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(e)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,296</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(4,657</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">526</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Purchase accounting adjustments<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(f)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">37</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(3,787</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,799</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Acquisition-related costs<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(g)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">13</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(4,025</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">241</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Certain significant items<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(h)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">56</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(1,511</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Other unallocated<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(i)</sup></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">560</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">(123</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">109</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="top"><font size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$49,269</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$7,824</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$10,674</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$4,757</font></td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> </tr> <!-- End Table Body --></table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Income from continuing operations before provision for taxes on income.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Certain production facilities are shared. Depreciation is allocated based on estimates of physical production.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">For 2011, includes King commencing on the acquisition date of January&#xA0;31, 2011. For 2009, includes Wyeth commencing on the acquisition date of October&#xA0;15, 2009.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(d)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Other business activities includes the revenues and operating results of Pfizer CentreSource, our contract manufacturing and bulk pharmaceutical chemical sales operation, and the research and development costs managed by our Worldwide Research and Development organization and our Pfizer Medical organization.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(e)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Corporate for R&amp;D expenses includes, among other things, administration expenses and compensation expenses associated with our research and development activities and for Earnings includes, among other things, administration expenses, interest income/(expense), certain compensation and other costs not charged to our operating segments.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(f)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Purchase accounting adjustments include certain charges related to the fair value adjustments to inventory, intangible assets and property, plant and equipment.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(g)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Acquisition-related costs can include costs associated with acquiring, integrating and restructuring newly acquired businesses, such as transaction costs, integration costs, restructuring charges and additional depreciation associated with asset restructuring (see <i>Note 3. Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives</i> for additional information).</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(h)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Certain significant items are substantive, unusual items that, either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular basis. Such items primarily include restructuring charges and implementation costs associated with our cost-reduction and productivity initiatives that are not associated with an acquisition, the impact of certain tax and/or legal settlements and certain asset impairments.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(i)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Includes overhead expenses associated with our manufacturing and commercial operations not directly attributable to an operating segment. In 2009, R&amp;D expenses include approximately $550 million of Wyeth R&amp;D expenses and Earnings include approximately $900 million of Wyeth earnings and $290 million of operating expenses incurred in Japan&#xA0;associated with our three biopharmaceutical operating segments, where allocation among the segments is not practicable.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="1%"></td> <td valign="bottom" width="1%"></td> <td width="98%"></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="2"><b>B.</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 3px"> &#xA0;</p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px"><font style="FONT-FAMILY: ARIAL" size="2"><b>Geographic Information</b></font></p> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">Revenues exceeded $500 million in each of 18 countries outside the U.S. in 2011 and 2010, and in each of 13 countries outside the U.S. in 2009. The U.S. was the only country to contribute more than 10% of total revenues in each year.</font></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">Revenues by geographic region follow:</font></font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="76%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> &#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: ARIAL" size="1">YEAR ENDED DECEMBER 31,</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> </tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">(MILLIONS OF DOLLARS)</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" colspan="2" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2011</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2010</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2009&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Revenues<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">United States</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;&#xA0;&#xA0;$</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>26,933</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;&#xA0;&#xA0;$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">28,855</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;&#xA0;&#xA0;$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">21,540&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Developed Europe<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>16,297</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">16,345</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">12,586&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Developed Rest of World<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>11,091</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">10,008</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">8,097&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Emerging Markets<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(d)</sup></font></p> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>13,104</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">11,849</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">7,046&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Consolidated</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;&#xA0;&#xA0;$</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>67,425</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;&#xA0;&#xA0;$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">67,057</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;&#xA0;&#xA0;$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">49,269&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> </tr> <!-- End Table Body --></table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">For 2011, includes King commencing on the acquisition date of January&#xA0;31, 2011. For 2009, includes Wyeth commencing on the acquisition date of October&#xA0;15, 2009.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Developed Europe region includes the following markets: Western Europe, Finland and the Scandinavian countries. Euro revenues were approximately $12 billion for each of 2011 and 2010 and $10 billion for 2009.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c</sup><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Developed Rest of World region includes the following markets: Australia, Canada, Japan, New Zealand, and South Korea.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(d)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Emerging Markets region includes, but is not limited to, the following markets: Asia (excluding Japan and South Korea), Latin America, Middle East, Africa, Central and Eastern Europe and Turkey.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">Long-lived assets by geographic region follow:</font></font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="87%"></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> &#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="5">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> &#xA0;</td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: ARIAL" size="1">AS&#xA0;OF&#xA0;DECEMBER&#xA0;31,</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> </tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">(MILLIONS OF DOLLARS)</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" colspan="2" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2011</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2010&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1">Property, plant and equipment, net</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">United States</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$&#xA0;&#xA0;7,893</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$&#xA0;&#xA0;8,537&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Developed Europe<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>6,023</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">7,159&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Developed Rest of World<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>904</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">854&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Emerging Markets<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2,118</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,095&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Consolidated</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$16,938</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$18,645&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-TOP: #000000 1px solid" valign="bottom">&#xA0;</td> </tr> <!-- End Table Body --></table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Developed Europe region includes the following markets: Western Europe, Finland and the Scandinavian countries.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b</sup><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Developed Rest of World region includes the following markets: Australia, Canada, Japan, New Zealand, and South Korea.</font></p> </td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: ARIAL" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup>&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: ARIAL" size="1">Emerging Markets region includes, but is not limited to, the following markets: Asia (excluding Japan and South Korea), Latin America, Middle East, Africa, Central and Eastern Europe and Turkey.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 10px"> <font style="FONT-FAMILY: ARIAL" size="2">&#xA0;</font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="1%"></td> <td valign="bottom" width="1%"></td> <td width="98%"></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="2"><b>C.</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 3px"> &#xA0;</p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px"><font style="FONT-FAMILY: ARIAL" size="2"><b>Other Revenue Information</b></font></p> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1"><u>Significant Customers</u></font></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">We sell our products primarily to customers in the wholesale sector. In 2011, sales to our three largest U.S. wholesaler customers represented approximately 13%, 10% and 9% of total revenues and, collectively, represented approximately 13% of total accounts receivable as of December&#xA0;31, 2011. These sales and related accounts receivable were concentrated in our three biopharmaceutical operating segments. In 2010, sales to our three largest U.S. wholesaler customers represented approximately 14%, 10% and 9% of total revenues and, collectively, represented approximately 18% of total accounts receivable as of December&#xA0;31, 2010.</font></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1"><u>Significant Product Revenues</u></font></font></p> <p style="MARGIN-TOP: 8px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: ARIAL" size="2"><font style="FONT-FAMILY: ARIAL" size="1">Significant product revenues follow:</font></font></p> <p style="MARGIN-TOP: 10px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="78%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="12"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;YEAR&#xA0;ENDED&#xA0;DECEMBER&#xA0;31,&#xA0; &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">(MILLIONS OF DOLLARS)</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom" colspan="2" align="right"> <font style="FONT-FAMILY: ARIAL" size="1"><b>2011</b></font></td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2010</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2009&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom" colspan="12"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: ARIAL" size="1"><b>Revenues from biopharmaceutical products</b><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(a)</sup><b>:</b></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td bgcolor="#E6E7E8" valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Lipitor<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(b)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>$9,577</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$10,733</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">$11,434&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Lyrica</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>3,693</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">3,063</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,840&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Prevnar 13/Prevenar 13<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>3,657</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,416</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Enbrel (Outside the U.S. and Canada)<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>3,666</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">3,274</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">378&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Celebrex</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>2,523</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,374</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">2,383&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Viagra</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,981</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,928</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,892&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Norvasc</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,445</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,506</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,973&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Zyvox</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,283</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,176</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,141&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Xalatan/Xalacom</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,250</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,749</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,737&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Sutent</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,187</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,066</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">964&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Geodon/Zeldox</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,022</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,027</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,002&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Premarin family<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>1,013</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,040</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">213&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Genotropin</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>889</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">885</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">887&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Detrol/Detrol LA</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>883</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,013</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,154&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Vfend</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>747</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">825</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">798&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Chantix/Champix</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>720</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">755</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">700&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">BeneFIX<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>693</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">643</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">98&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Effexor<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>678</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,718</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">520&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Zosyn/Tazocin<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>636</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">952</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">184&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Pristiq<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>577</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">466</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">82&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Zoloft</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>573</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">532</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">516&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Caduet</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>538</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">527</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">548&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Revatio</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>535</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">481</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">450&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Medrol</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>510</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">455</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">457&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">ReFacto AF/Xyntha<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>506</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">404</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">47&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Prevnar/Prevenar (7-valent)<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>488</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">1,253</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">287&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Zithromax/Zmax</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>453</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">415</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">430&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Aricept<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(d)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>450</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">454</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">435&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Fragmin</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>382</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">341</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">359&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Cardura</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>380</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">413</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">457&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Rapamune<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>372</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">388</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">57&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Aromasin</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>361</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">483</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">483&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">BMP2<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>340</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">400</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">81&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Relpax</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>341</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">323</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">326&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Xanax XR</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>306</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">307</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">318&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Tygacil<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(c)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>298</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">324</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">54&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Neurontin</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>289</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">322</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">327&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Diflucan</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>265</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">278</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">281&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Arthrotec</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>242</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">250</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">270&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Unasyn</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>231</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">244</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">245&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Sulperazon</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>218</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">213</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">204&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Skelaxin<sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">(e)</sup></font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>203</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: ARIAL" size="1">Inspra</font></p> </td> <td bgcolor="#E6E7E8" valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td bgcolor="#E6E7E8" valign="bottom"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" align="right"><font style="FONT-FAMILY: ARIAL" size="1"><b>195</b></font></td> <td bgcolor="#E6E7E8" valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: ARIAL" size="1"><b>&#xA0;&#xA0;</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</fo